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GLOSSARY

Chemical Abstracts Service (CAS) Number: – a CAS# or CASRN is a unique numeric
identifier assigned to “nearly every known chemical, compound or organic substance
(ILFI, 2014, p. 70).
Toxicity: the degree to which a substance has adverse impacts on an organism’s health.
Toxicological profile: “an examination, summary, and interpretation of a hazardous
substance to determine levels of exposure and associated health effects (US EPA
Terminology Services, 2009).
Green chemistry: “an analytical framework that encompasses both the science of safer
chemistry and the laws and policies that will motivate its development and adoption by
society” (Wilson & Schwarzman, 2009, p. 1204).
Voluntary material health program: for the purpose of this current research, this refers
to product inventory and material health assessment programs that “encourage industry to
move away from all hazardous ingredients...towards ingredients that are inherently safer”
(Heine, Kausch, Klosterhaus, Glass, & Lent, 2013, p. 6).
Optimization: for the purpose of this study, optimization refers to improvement of the
toxicological profile of a product through the selection of chemicals established to be
safer for human and ecological health.
Precautionary Principle – “When an activity raises threats of harm to human health or
the environment, precautionary measures should be taken even if some cause and effect
relationships are not fully established scientifically” (SEHN, 1998).
Chemicals of Concern – according to the US Environmental Protection Agency,
Chemicals of Concern are those which raise “serious environmental or health concerns”

xii
and in some cases “may present an unreasonable risk of injury to health and the
environment” (Grossman, 2010).
Final manufacturer – herein defined as the consumer-facing manufacturer in control of
the final point of assembly or production for a product.
Disclosure – herein defined as the act, or result, of sharing information about product
content inventory at some level.
Threshold: “concentration(s) above which substances present within the material are
itemized by the manufacturer or supplier” (HPDC, 2015, p. 55).

xiii

LIST OF ABBREVIATIONS

C2C: Cradle to Cradle
C2CPII: Cradle to Cradle Products Innovation Institute
CASRN or CAS#: Chemical Abstract Services Registry Number
EPA or USEPA: US Environmental Protection Agency
HPD: Health Product Declaration
HPDC: Health Product Declaration Collaborative
ILFI: International Living Future Institute
LBC: Living Building Challenge
LCA: Life Cycle Analysis
LEED: Leadership in Energy and Environmental Design
ppm: parts per million
RSL: Restricted Substances List
USGBC: US Green Building Council
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ABSTRACT

Muller, Alexandra A. MS Technology, Purdue University, August 2016. Manufacturer
Perspectives on Content Transparency and Material Health in the US Building Products
Industry. Major Professor: Dr. Michael Dyrenfurth.
Flawed U.S. federal regulation of chemicals has resulted in a materials market that
undervalues human and environmental health in favor of the more traditional attributes of
price, performance and aesthetics. In the building products industry, global, dynamic
supply chains and proprietary information concerns further complicate the task of
assessing the material health of products.
Voluntary material health programs in the green building industry are intended to
incentivize the manufacture and selection of safer products by getting companies to
gather and assess ingredient, hazard and risk information from their supply chain.
Building product manufacturers considered early adopters of the main material health
programs of interest were interviewed and surveyed in order to identify the barriers they
face to further program adoption and disclosure of product content and hazard
information.
The research reinforced findings that data collection requirements should be further
aligned between different material health programs in order to streamline the process for
manufacturers. Release of appropriate levels of information for consumers is also crucial
to incentivizing informed decision-making. Supplier engagement and consumer
education were identified as pathways to accelerating the demand and release of better
information. Addressing these barriers is important to progress, as voluntary measures are
likely to remain the most efficient pathway to a healthier materials market.
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CHAPTER 1. INTRODUCTION

1.1

Introduction

This chapter provides an overview of the proposed research. It discusses the justification
for the subject of the study, the problem to be addressed and the significance of the study.
It then outlines the research questions and scope of the study. Assumptions, limitations,
and delimitations are used to further refine the research scope.

1.2

Problem Statement

Gaping holes in U.S. federal regulation of chemicals under the Toxic Substances Control
Act (TSCA) have perpetuated a materials market that highly undervalues safety in favor
of price, performance and function (Wilson & Schwarzman, 2009). Though it was
designed to strengthen federal control of chemical regulation, TSCA lacks both the
authority to mandate the release of the large majority of chemical hazard information
from manufacturers, as well as the means to incentivize investment in better production
and products (Scruggs, 2013; Wilson & Schwarzman, 2009). Thus, despite mounting
evidence of the negative toxicological impacts of thousands of unregulated chemicals on
both humans and the environment, the data gap of chemical information continues to
widen over time, further stymying progress.
In the building industry, complex, often global supply chains, competition, and concerns
about intellectual property further cloud an already opaque flow of chemical information.
In the absence of mandated disclosure of product information or optimization of
ingredients, a number of voluntary material health evaluation programs have been
developed in an effort to narrow the hazard data gap and prioritize action. These
programs also provide much-needed incentives for manufacturers to produce safer
products and for architects to specify those products.
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Increasing the quality and quantity of product and chemical data, and the sharing of that
information, is particularly important for encouraging a healthier materials market. The
flow of adequate and appropriate information is important for stakeholders both within
supply chains and outside to consumers and policymakers, among others (Fransson,
Brunklaus, & Molander, 2013; Kogg & Thidell, 2010). If a company is not fully aware of
what is in its products it is impossible for them to confidently avoid toxic chemicals or
ensure the delivery of products safe for human and environmental health.
A push for greater disclosure of chemical and hazard information, often described as
transparency, is occurring globally, across many industries. Achievement of this outcome
can be particularly challenging in the often conservative, and commodity-based building
products industry (Hoffman & Henn, 2008; Kamrin, 2014). Theoretically, transparency
should allow users to make informed, and thus rational decisions. However, the level,
format and nature of that disclosure and transparency are of great debate in the industry.
A product sustainability manager for a large US manufacturing company asked:
Is transparency a self disclosed list of raw materials? A self-disclosed list
of what I think I know is in my product? A third-party vetted review of
what is in my product as told by the raw material supplier? Declarations
on the presence or absence of ‘Listed Chemicals’? Some combination of
one or more of these? (Correspondence, 2015)
It is important to understand how manufacturers in the building industry are responding
to the push for information disclosure within the framework of voluntary material health
programs. Understanding how key stakeholders in the manufacturing supply chain
interpret and act on principles of material health and transparency may help to identify
where gaps exist between program intent and implementation, as well as between
manufacturers and their consumers. In turn, identifying barriers currently impeding
further program adoption may help lead to a materials market that values health alongside
traditionally-valued product attributes.
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1.3

Statement of Purpose

The purpose of this current research is to learn what manufacturers perceive as the main
barriers to ingredient and hazard disclosure in the US building products industry.
Aggregating the voices of manufacturers to understand the motivation for and challenges
to collecting and disclosing material health information will help to identify potential
pathways forward to overcoming barriers and achieving broader adoption of voluntary
material health programs with significant benefit to humans and the environment.
Additionally, how manufacturers are interpreting the concepts and standards of chemical
hazard information in response to requests material health disclosure may reveal
disparities between program intent and practice. Better design of voluntary material
health programs based on feedback from manufacturers can lead to further harmonization
and alignment between programs, better data, clearer interpretation of that data; all
leading to healthier products.

1.4

Statement of Significance

There are more than 84,000 chemicals used commercially today, the toxicological
impacts of which are known for only a small percentage (Scruggs, 2013). The presence of
most chemicals has regularly been tolerated by consumers because of lack of awareness
of some of the issues inherent in their use, and because of an assumption that legality of
chemical use can be equated with safety (Scruggs & Van Buren, 2014). This incorrect
assumption has persisted despite mounting evidence of the human and environmental
toxicological impacts of many chemicals. It is an assumption that has been built into US
federal chemical regulation (Scruggs, 2013).
Federal regulation of chemicals in the US falls largely under the TSCA’s jurisdiction.
Though the jurisdictional reach of TSCA is incredibly broad, significant gaps in
enforcement, legal tools and market incentives, have largely prevented the statute from
being effective (Scruggs & Ortolano, 2011). As a result, toxicological data and safety are
still treated as an afterthought, rather than as key factor in product development. The act
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has created direct barriers to the progress of green chemistry science and policy by
allowing unsafe chemicals to remain competitive and legal.
In the absence of effective federal regulation, a number of regulatory and market forces
have recently begun to push the industry to “green” products and operations (Lowell
Center for Sustainable Production, 2009). These forces include, but are not limited to:
•

green consumerism

•

consumer demand for chemical transparency

•

regulatory programs (i.e. international, state-level regulation)

•

green building and green product certification programs

Voluntary green building certification programs provide a measuring stick for actions
beyond regulation and are able to reward adherence to more restrictive standards than
regulation. The shift in the green building industry towards broader material health
considerations can be seen in some of the most prominent green building standards,
including Leadership in Energy and Environmental Design Version 4.0 (LEEDv4) and
the Living Building Challenge (LBC), among others. These certifications, among others,
include options for pursuing voluntary material health programs, further incentivizing
architects to select toxicologically preferable materials, and pushing manufacturers to
comply with stricter standards for health, safety and transparency of products. The three
particular material health programs studied in this current research are the Health Product
Declaration (HPD), Declare Products (Declare) and Cradle to Cradle (C2C). This is due
to their specification within the LEEDv4 standard and LBC in particular, and because
some harmonization and alignment already exists between these programs (Heine et al.,
2013). Each program aims to help manufacturers better understand what is in their
product with the intent of ultimately improving the toxicological profile of products,
though each takes a very different approach to this task; some simply aid manufacturers
in taking stock of what is in their product and screening it to determine if problematic
chemicals are present, all the way to requiring chemical assessments of ingredients,
exposure analyses, and making improvements to the formulation.
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The life cycle of a building product is often long and complex, involving a large number
of stakeholders along the way. Final manufacturers of products are the main adopters of
material health programs due to their consumer-facing position at the end of the
manufacturing supply chain. They are the initial point of contact for architecture and
design firms attempting to specify non-toxic materials and request information, and their
products represent the culmination of complex, often global supply chains (Fransson &
Molander, 2012). As the focal point of the supply chain in between supply and demand,
final manufacturers are often the most familiar with material health programs and issues
of disclosure and transparency.
The current research aims to contribute to a broader understanding about how
manufacturers are interpreting the call for ingredient and hazard transparency in the
building products industry. Previous research has explored the barriers faced by
consumer product manufacturers in gathering information from their supply chain, as
well as the motivations for proactive chemical policies in manufacturing companies
(Lowell Center for Sustainable Production, 2008, 2009; Scruggs & Ortolano, 2011).
However, no studies to date have focused specifically on transparency and disclosure in
the building industry, nor the role voluntary material health programs are playing in
moving the industry forward.
It may also be important for certification program developers to better understand how
their tools are being used, in relation to the intent for their use. Manufacturer perspectives
on the principles of material health and disclosure and their perception of each program’s
abilities to deliver these principles, may allow program developers to design more
effective programs. Therefore the significance of the current work is its ability to inform
the ongoing adaptation of existing programs; thereby encouraging broader adoption of
material health disclosure and optimization, both individually, and also collectively, and
consequentially benefits for human and environmental health impacts of building
materials.
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1.5

Research Questions

The following questions guided this research:
1. What are the barriers, both real and perceived for U.S. building product
manufacturing companies to engaging with voluntary material health programs?
2. What is the manufacturer evaluation of the three main material health programs?
What are the barriers to adoptions? What are the benefits to participation?
3. How do manufacturers define transparency? To what extent do manufacturers feel
transparency is a prerequisite to achieving a building product industry that is safe
for humans and the environment?

1.6

Assumptions

The following assumptions were made in this study:
•

Manufacturers that are interacting with voluntary material health programs in the
building products industry are industry leaders on issues of material health and
transparency.

•

Manufacturers, architects, tool developers, and other stakeholders along the
product supply chain share a common goal of improving the toxicological profile
of products

1.7

Scope and Delimitations

This research is not an exhaustive look at existing material health programs, nor does it
attempt to rank those programs within its scope. All of the programs take a different
approach, resulting in a different outcome.
The Health Product Declaration (HPD) standard, Cradle to Cradle (C2C) certification
standard, and Declare are some of the main voluntary material health product programs
in use right now, due in part to their inclusion green building certifications such as
LEEDv4 and LBC. Therefore, this study will focus on analyzing the manufacturer
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perspective on only these three programs. The existence of other programs and their
competition for similar space in the materials market is acknowledged.
All of the programs share the goals of improving material hazard and chemical ingredient
communication in the building industry, as well as supply chain integration. Based on
their different philosophies, each program approaches these issues from a different
perspective. The goals of the current research are to understand why manufacturer may
prefer one pathway over another, what manufacturers perceive to be barriers to and
benefits of each program, and to identify pathways for broader adoption industry wide.
The delimitations for this study were as follows:
•

Participants were limited to manufacturers in the building material industry

•

Manufacturers outside of the U.S. were not included in the study

•

Manufacturers were proactive in the world of chemical assessments and
disclosure, so that they would have greater insight into best practice

•

The research focused on only three material health evaluation programs: Health
Product Declaration, Cradle to Cradle, and Declare Products.

1.8

Chapter Summary

This chapter introduced the problem of inadequate chemical regulation in the U.S. and its
impact in shaping a product market that undervalues human and environmental health in
favor of price and performance attributes. Consumer interest in manufacturer
transparency around product ingredient and hazard content, and the resulting trend
towards increased information disclosure in the building products industry was discussed.
The need for research to better understand key stakeholder perspectives on issues of
material health and chemical transparency was raised. Parameters of the research were
defined by presenting the research questions, deliverables and significance of the study.
The assumptions, limitations and delimitations of the study were used to further refine the
research scope.
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CHAPTER 2. REVIEW OF THE LITERATURE

2.1

Introduction to the Review of the Literature

This chapter provides the reader with an introduction to the shortcomings of US federal
chemical regulation. It describes the increasing push globally for product information and
manufacturer transparency. The role of green building certification programs and
material health programs in addressing human and environmental health concerns around
building products is discussed. The chapter also introduces some existing research on the
barriers to obtaining ingredient and hazard information for products and the complexity
involved in publicly disclosing product ingredient and hazard information.

2.2

Ubiquity of Chemicals in Modern Society

Nearly everything we manufacture is been made from, treated with, or coated in
chemicals in some manner. Synthetic chemicals “now constitute the primary material
base of society” (Wilson & Schwarzman, 2009). The role of the U.S. chemical industry in
shaping modern lives and the national and global economies cannot be overstated.
Chemical innovation and production has, as a result, had innumerable direct and indirect
benefits on the economy and modern society.
Chemicals created or used for one purpose may nonetheless also produce unintended
consequences. These negative externalities of chemicals are “expressed as human and
environmental risks” (Koch & Ashford, 2006). The potential for negative externalities
exists throughout the full life cycle of a chemical, from raw material extraction to
production and transportation, to application and disposal. Similar to carbon emissions
and pollution externalities, our economy has long allowed producers to operate without
taking these impacts into account.
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This extreme dependence on chemical usage is very much at odds with a dearth of
information and understanding about the impacts of the vast majority of chemicals
throughout their life cycle. Manufacturers have been able to operate without sufficient
knowledge of what their products contain and what impacts they might have. In turn,
consumers lack the ability to make informed decisions about what products to use and
how to use them.
In the wake of rising health issues tied to issues of chemical usage, it is important to
recognize that of the over 84,000 unique chemicals used commercially today,
toxicological data is available for only a very small percentage of these (Markell, 2010;
Scruggs, 2013).
The presence of most chemicals in products has been largely tolerated by consumers a)
because of a lack of awareness of some of the issues inherent in their use, b) because of
an inability to determine what is in products or how to choose safer ones and b) because
of an incorrect assumption that legality of chemical use can be equated with safety under
US chemical regulation. The presumption of safety of existing chemicals was in fact
written into US federal chemical regulation, despite mounting volume of scientific
evidence to the contrary (Scruggs, 2013).

2.3

US Federal Chemical Regulation

In the late 1960’s and early 70’s, public perception of inadequate control of toxic
chemicals was building support for increased regulation. The Council on Environmental
Quality (CEQ) wrote that (1) toxic substances were making their way into the
environment, (2) that the negative impacts of those substances was substantial, (3) that
legal authorities lacked the ability to remedy this issue, and therefore (4) a new legal
authority was required (Markell, 2010).
National media coverage around the role of Kepone, an insecticide, in causing
neurological disorders in factory workers, fed public pressure to prevent these types of
tragedies from being repeated. The incident helped to build consensus for the passage of
TSCA, six years after its introduction in Congress. One of the bill’s sponsors, Senator
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Pearson, said at the time, “We can no longer operate under the assumption that what we
do not know about a chemical substance cannot hurt us. Tragic results associated with too
many toxic substances have taught us that lesson all too well. Chemicals, not people,
must be put to the test” (Markell, 2010). TSCA was signed into law in 1976 (Kapp, 2014).

2.3.1 Gaps in Federal Regulation
TSCA was designed to broaden federal oversight a chemicals market that lacked “any
form of accountability or oversight” (Wilson & Schwarzman, 2009). TSCA is the only
federal regulation in the US “governing chemical manufacture, importation, distribution,
and use” (C. E. Scruggs & Van Buren, 2014) intended to regulate chemicals both before
and after entering the market. The thought was that TSCA would improve the “toolbox”
available to the EPA (Markell, 2010), which at that point also included the Clean Water
Act, Clean Air Act, Comprehensive Environmental Response, Compensation and
Liability Act (CERCLA), and others. The other laws are mostly limited to end-of-pipe
statutes pertaining only to chemicals already on the market, and only covered 1,134
chemicals and pollutants as of 1997.
On paper, “TSCA has a potentially enormously…broad jurisdictional reach” (Markell, p.
352). The definition of chemical substances by Congress is inclusive of “[[a]ny organic
or inorganic substance of a particular molecular identity, including—(i) any combination
of such substances occurring in whole or in part as a result of a chemical reaction or
occurring in nature and (ii) any element or uncombined radical” which includes even
microorganisms (Markell, 2010, p. 351-352).
However, while the scope of TSCA is technically inclusive of the approximately 84,000
chemicals in use today (Markell, 2010), loopholes and gaps in that same act have deeply
undermined the ability of the EPA to adequately regulate those chemicals. TSCA’s
impact on the great majority of chemicals it governs has been minimal. In fact, the act has
all but prevented the assessment of hazard traits for most chemicals in use, the control of
chemicals of concern, and the advance of green chemistry efforts.
Wilson & Schwarzman (2009) attribute this failure to three main gaps in the act:
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•

Data gap: regulation does not compel chemical producers to produce or disclose
product hazard information

•

Safety gap: the government does not have the legal tools necessary to “identify,
prioritize, and take action to protect public and environmental health”

•

Technology gap: lack of market incentives for innovation or investment in green
chemistry efforts or safer chemicals.

At the time of its passage, TSCA grandfathered in a large majority of existing chemicals
(approximately 62,000) “assuming them to be safe since they were already in use”
without requiring toxicological or hazard information about them (Scruggs & Ortolano,
2011). The Environmental Protection Agency (EPA) lacks the power necessary to extract
this vital information from producers and manufacturers. TSCA “creates perverse
incentives for health and safety information about chemicals to be not produced, and if
produced, not fully disclosed” (Kokai, 2014). The EPA is unable to close this data gap
and is therefore unable to prioritize the removal of certain chemicals. Only about five
chemicals or chemical classes have been significantly regulated under TSCA. These
interlocking problems reinforce one another, resulting in a market that undermines health
and safety and act as a direct barrier to green chemistry by keeping harmful materials
price competitive with safer ones (Kokai, 2014; Wilson & Schwarzman, 2009).
After 40 years without significant updates to the act, the Frank R. Lautenberg Chemical
Safety for the 21st Century Act was signed into law on June 22nd, 2016. The act is
designed to remove some of the barriers preventing action by the EPA within TSCA and
its bi-partisan passage has been celebrated by many politicians and by chemical and
industry groups. The act gives the EPA more power to prevent dangerous chemicals from
going to market and addresses some issues of prioritization of reviews, among other
changes. However, other stakeholders including many environmental organizations, view
the update as inadequate, citing a lack of funding for the implementation of the changes,
and criticizing perceived added limitations to state-level regulation of chemicals
(Kollipara, 2015; Fears, 2016). The efficacy of these changes in incentivizing the
production and use of data, protection of consumers and investment in green chemistry
remains to be seen.
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2.4

A Growing Demand for Information

In the absence of strong top-down chemical regulation, global demand for information by
a wide number of stakeholders has nonetheless grown in recent years (Kogg & Thidell,
2010). Many industries are thus beginning to grapple with the challenges inherent in
gathering and disseminating this information.
The information demand generally focuses on product content, as “products are vehicles
through which chemicals travel through our societies” (Kogg & Thidell, 2010, p.37).
Products containing harmful chemicals have the potential to negatively impact
individuals and the environment throughout their full life cycle, from extraction to
manufacture to use and disposal. Therefore demand for information regarding product
content and toxicological impacts originates from a large number of stakeholder groups.
Self-imposed restrictions by manufacturers on the chemicals they purchase and use were
found by the Lowell Center for Sustainable Production (2008) to be driven by:
1. Regulatory Drivers – US manufacturers may still be affected by state-level, as
well as international, regulations (GC3, 2008).
a. In particular, the European Union’s REACH program (Registration,
Evaluation, Authorisation and Restriction of Chemicals) program came
into effect in 2007, and is being phased in through 2018. Designed to
“ensure a high level of protection of human health and the environment
from the risks that can be posed by chemicals, the promotion of alternative
test methods, the free circulation of substances on the internal market and
enhancing competitiveness and innovation”, REACH addresses some of
the gaps inherent in TSCA (European Commission, 2013). In a global
market, US manufacturers are not insulated from these regulations.
REACH requirements apply to imported goods as well as those produced
within the EU.
b. California’s Proposition 65 is an example of state-level regulation that has
had impact beyond its borders. One of the purposes of the act was to
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protect the public from CMRs (Carcinogens, Mutagens and Reproductive
Toxins) (Lowell, 2008).
2. Marketing Drivers – Purchasing programs are popping up in a number of
industries, from food stores to “big box” stores to building material retailers.
Compliance with a retailer materials program is required for a company to sell
their products within that store. Walmart “Preferred Chemicals” program is one of
the best known of these initiatives. Walmart began tracking hazardous chemicals
sold in their stores in 2004, and moved from a purely restricted substances list
approach in 2008 to a third-party screening process using a tool called
GreenWERCS. These can be huge incentives for manufacturers selling consumer
products.
3. Advocacy Drivers – NGOs and advocacy groups play a large role in changing
how manufacturers approach the use of chemicals. In particular, their ability to
create product standards and certification programs that go beyond regulation
satisfies a demand for standardization and communication with consumers.
This current research focuses on the role of advocacy in motivating manufacturers to
gather and disseminate chemical and hazard information through voluntary certification
programs and standards.

2.5

MSDS and SDS

The U.S. Occupational Safety and Health Administration (OSHA) require that
information about potentially harmful substances handled in the workplace be made
available to employees. This previously took the form of the Material Safety Data Sheet,
or MSDS, standardized information transmission sheets used to communicate
“performance characteristics, safe handling and transport, and basic hazard and
toxicological information” (Lowell, 2009, p. 4). However, many MSDSs are woefully
incomplete in terms of chemical ingredients and toxicological data.
Following the UN Conference on Environment and Development in Rio de Janeiro in
1992, the U.S. was one of 65 countries so far to adopt a globally harmonized system of
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classification and labeling of chemicals. The MSDS thus became the Safety Data Sheet,
(SDS) which now follows a more standardized 16-section format covering information
from human and environmental health hazards, exposure control, protective measures,
and safety precautions (OSHA, 2016).
2.6

Hazard vs. Risk

MSDS and SDS were “primarily designed to provide information on mostly acute
occupational health hazards, not those throughout an entire product lifecycle” and are
therefore inadequate for informed decision-making in selecting safer materials and
products (Lowell, 2009, p. 4). Approaches to material health generally revolve around
two these concepts of hazard and risk. Hazard refers to a substance’s inherent “potential
to cause adverse health or environmental effects” (Rossi, 2015). These characteristics are
intrinsic, regardless of the context in which the product is manufactured, used, or
disposed of. The likelihood that a substance will cause harm within a certain context is a
question of risk. Hazard exists regardless of risk, but risk cannot exist without hazard.
Risk “is defined as a function of hazard and exposure” and is therefore dependent on the
amount, timing, duration, and pathway (i.e. inhalation, ingestion, touch) of exposure, as
well as its interaction with other environmental factors (Rossi, 2015).

Figure 2.1. Hierarchy of Controls. (Rossi, 2015)
Therefore an approach that physically removes hazards is considered by the Center for
Disease Control to be the most effective, rather than minimization of risk and exposure
(Figure 2.2).
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2.7

Green Building and Health

The construction industry has arguably the largest environmental impact of any economic
activity. The industry accounts for 40% of the world’s greenhouse gas (GHG) emissions,
and uses 40% of global total primary energy (Assefa et al., 2007; Ding, 2014). From raw
material extraction, through construction and maintenance, renovation and end-of-life
disposal, buildings cause both direct and indirect harm to the environment.
Green building began as a narrowly-focused attempt to increase the efficiency of the built
environment (Espinoza, Buehlmann, & Smith, 2012; Isnin, Ahmad, & Yahya, 2012). The
movement was mainly triggered by the fear of fossil fuel dependence in the wake of the
1973 OPEC oil embargo and capitalized on an increased awareness of the environmental
impact of human activity and construction (Cassidy, 2003; Ding, 2014). Over time, our
evolving understanding of what it means to be sustainable has built a more holistic
picture of green building beyond the narrow focus of energy efficiency. The U.S. Office
of the Federal Environmental Executive defined green buildings as resource efficient, and
also those “[reduce] building impacts on human health and the environment through
better siting, design, construction, operation, maintenance, and removal - the complete
building life cycle” (Cassidy, 2003, p. 4).
While indoor air quality and daylighting have been considerations for a relatively longer
period of time, the health impacts of the products that comprise a building have more
recently become a focus of green building efforts. The average American spends over 90%
of their time indoors, thus the requirement that buildings be healthy, in addition to
efficient, has emerged as a new driver in the green building movement (Ding, 2014).
Today, “reducing the toxicity of building materials is part of the ‘greening’ process, and
avoiding the use of materials that release pollutants is one of the principles of ecoefficient construction” (Pacheco-Torgal, 2012, p. xv).
A number of voluntary material health evaluation programs have thus arisen out of the
demand for product and chemical information and assurance of product safety in the
building industry. Their recent incorporation into well-known green building
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certifications like LEEDv4 and LBC further incentivize manufacturer involvement with
these platforms, and the collection and dissemination of material health information.
The LEED green building standard has been particularly effective in introducing building
designers and contractors to the concepts of energy efficient building design since the
1990’s (Lee & Kim, 2008). As of April 2016, LEEDv4 now has a “Building Product
Disclosure and Optimization – Material Ingredients” credit, pathways to which include
product compliance with material health programs including Declare, Cradle to Cradle
(C2C), and the Health Product Declaration (HPD) Standard.
The Living Building Challenge (LBC), a green certification and advocacy program
administered by the International Living Future Institute (ILFI), is considered to be one
of the most stringent green building certifications in existence. The Challenge is
comprised of seven performance categories called “Petals”: Place, Water, Energy, Health
& Happiness, Materials, Equity and Beauty.
One of the biggest barriers to achievement of the Living Building Challenge is the Red
List. The Red List is a restricted substances list, which bans the use of 22 classes of
chemicals, or 777 individual CASRNs in Living Building projects. Therefore, projects
pursuing the Materials Petal of LBC must make sure all products used have been
screened against the Red List and do not contain any Red List materials. The goal is to
push the principles of transparency and move the materials market to “eliminate the use
of worst-in-class materials/chemicals with the greatest impact to human and ecosystem
health” (ILFI, 2014, p. 6). The Red List continues to evolve, intended to act as a means to
transform the materials market (S. Wright, personal communication, 2014). The Declare
product ingredient transparency program was created by ILFI as a companion to the Red
List in order to aid project designers looking for products free of Red List ingredients.

2.8

Voluntary Material Health Programs

The number of ecolabels across many industries has exploded over the last few years
(Basu & Bidanda, 2014). A number of these now approach the issue of material health in
some form. A finished product is the synthesis of different materials, and those materials
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in turn, are composed of different chemicals. There is significant debate over the best
level at which to analyze a product, to determine a product’s hazard profile, and to
communicate content and hazard information. Kokai (2014) describes this ‘design
hierarchy’ (Figure 2.2) and the degrees that often separate the makers of a final product
from the chemicals from which it is built. Each of the programs studied in this research
takes a different approach to the issue of material health.

Figure 2.2. Design hierarchy (Kokai, 2014)

Within the building industry, the three programs selected for this current research (HPD,
Declare, and C2C) were selected based on a) the ability of all building product
manufacturers to engage with them, b) ongoing program harmonization efforts between
the groups, and c) their inclusion as a pathway for material health in the LEEDv4 and
LBC standards.
Both LEED and LBC thus incentivize the pursuit of certain voluntary material health
programs, designed to inform the production of safer materials in the supply chain, and
encourage the selection of better products by design teams, thereby rewarding
manufacturers engaging with these programs. Material health programs are designed to
facilitate “informed judgment,” at different levels, standardizing and adding rigor to how
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we compare and select chemicals, materials and products (Kokai, 2014). Each of the
programs studied within this research approaches the issues of material health and
ingredient disclosure differently, particularly by incorporating hazard and/or risk.
Each of the programs studied in this current research and their approach to material
health are described in the following sections.
2.8.1

GreenScreen for Safer Chemicals

Although GreenScreen is not a standard for final products, and was not studied
specifically in this research, it’s important to acknowledge the role of GreenScreen
because of its use in ingredient assessment and as a tool within other standards.
GreenScreen is a Chemical Hazard Assessment program developed by Clean Production
Action. The standard is freely and publicly accessible. The standard looks at 18 different
hazard endpoints (Figure 2.3) to determine the hazard levels for each.

Figure 2.3 GreenScreen Assessment example (Clean Production Action, 2016)

Based on these endpoints, an overall benchmark for chemicals on a scale of 1-4 (Figure
2.4) is then provided. Chemicals that lack enough information to make a determination
are labeled U for undetermined. Benchmark 1 chemicals should be phased out of
production, while Benchmark 4 chemicals are considered inherently safer.
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Figure 2.4. GreenScreen Benchmarking Scale (Clean Production Action, 2016)

The assessment encourages users to: assess and clarify ingredient hazards, apply the
overall benchmark system, and make informed decisions about which chemicals to use.
Benchmarking chemicals can make the chore of finding a substitute chemical easier, by
only having to locate a chemical with a better benchmark score. However, by combining
all of the hazard endpoints into one final score, users cannot see whether a chemical
performs higher or lower on specific endpoints, which can be an issue if certain endpoints
are more important to the user than others based on use, location or some other factor
(Kokai, 2014). Also, when chemicals are examined at the ingredient level, one is only
able to look at the inherent hazards present in the ingredient, and the system does not take
into account the risk of exposure in the ingredient’s state and combination with other
chemicals in a product. The Health Product Declaration uses the GreenScreen List
Translator tool to represent the known hazards for ingredients disclosed on the standard.
Cradle to Cradle uses a similar method to GreenScreen for assessing chemicals, however
C2C only looks at 14 hazard endpoints, and the program also takes into account productlevel risk and exposure.
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2.8.2

Health Product Declaration

The Health Product Declaration (HPD) form provides manufacturers with a standardized
format for content and hazard disclosure and communication. The standard was
developed and is overseen by the Health Product Declaration Collaborative (HPDC).
HPDs can either be self-disclosed or third party certified.
The HPD screens product ingredients against more than 30 separate hazard lists and the
GreenScreen List Translator benchmarks. There is a greater emphasis on disclosure of
GreenScreen hazard ratings than ingredient CAS #s. HPDs do not require a minimum
level of disclosure, but the form allows manufacturers to specify the level at which they
are disclosing. Figure 2.7 shows an example of an HPD. Within the continuum described
above in figure 2.5, the HPD is considered a tool for content inventory and screening.

Figure 2.5 Example HPD (Mohawk, 2016).
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Manufacturers have the option to choose the level at which they want to disclose. One
option is to disclose all known hazards without listing all of the chemicals in the product.
The other option is full chemical disclosure, in which 99% of the product by weight must
be accounted for. HPDs are intended HPD documents are intended to make clear what a
material contains, but they are also clear about what is withheld.
HPDs do not rate products, and are not directly linked to a building standard in the way a
Declare label is. They are intended to promote standardized sharing of information in
order to encourage a conversation on hazard reduction and continuous improvement
(HPDC, 2011). At the time of this research the HPD is in the process of transitioning to
the 2.0 standard, which makes some changes to the format of disclosure and the options
available to manufacturers regarding how they report their product contents.
2.8.3

Declare Products

Begun as a companion to the Living Building Challenge, Declare is often described as a
“food label” for building products. The label was developed as a tool for transparency
and market transformation, and aids LBC project teams pursuing LBC by providing a
clear way to understand whether a product does or does not contain the Red List
chemicals prohibited from use in LBC projects. Declare was also designed to encourage
ingredient transparency and change norms of proprietary and trade secret claims.
Declare itself is a content inventory and screening tool, however it differs from HPD in a
number of different ways. First, hazard ratings are not disclosed on the label or in the
Declare database. Second, all participating manufacturers are required to disclose the
ingredient name and CAS# for 99% of all intentionally added ingredients at the same
threshold of 100ppm in the final product. Third, the standard is tied to the LBC standard,
and therefore the presence or absence of Red List chemicals in a product determines
whether a product can be used in an LBC project. Any Declare labels that disclose 99.9%
of their ingredients now meet Option 2 of the Building Product Optimization and
Disclosure credit of the LEED v4 standard, incentivizing transparency.
Manufacturers are asked to self-disclose at least 99% of intentionally-added ingredients
in the product. Products then fall into one of three categories, or Declaration statuses:
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•

Red List Free: 100% of the final product content is disclosed at 100ppm and the
product contains no chemicals named on the LBC Red List

•

Red List Compliant: At least 99% of product content is disclosed. The product
of makes use of a temporary exception outlined in the LBC standard. This
exception may have to do with a) a product containing chemicals on the LBC Red
List that are allowable due to market realities or b) the product withholds up to 1%
of the product content to allow for retention of some proprietary information

•

Declared: The product is 100% disclosed, but contains some Red List materials.
These products are generally not allowed for use in LBC projects.

The Declare product labels and online database were designed to make the selection of
products for Living Building Challenge projects easier, and to increase manufacturer
product transparency. Products are assigned a “nutrition label” of ingredients (Figure 2.6),
making it easier to select LBC Red List-free building materials (ILFI, 2014). The label is
simple, and easy to read. Labels list the chemical names of ingredients, rather than CAS
numbers, or hazard ratings as the HPD does.
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Figure 2.6 Example Declare Label (ILFI, 2016)

Here, ‘optimization’ of products is indirectly encouraged because of a) automatic
qualification for Living Building Challenge projects if a product is Red List Free or Red
List Compliant and b) the Living Building Challenge mandates that project teams
advocate for manufacturer transparency when trying to obtain materials for LBC projects.
The label itself, however, does not require any optimization, nor does it require that
materials comply with the Red List.
2.8.4

Cradle to Cradle

Cradle to Cradle certification began in 2005 in order to certify products across industries
(not just building industry) and rates products on five impact categories:
•

Material health

•

Material reutilization

•

Water stewardship

•

Renewable energy and carbon management

•

Social fairness

Cradle to Cradle uses third party accredited assessors to collect, analyze, and evaluate
product data. Products are then given a rating from bronze to platinum in all five
categories, as well as an overall rating (Figure 2.7).
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Figure 2.7 Cradle to Cradle Product Scorecard (C2CPII, 2016)

Cradle to Cradle was a relatively early program in the material health arena. The
program requires inventory screening, and a minimum percentages chemical assessments
in the product to achieve each level of certification. The highest levels of Cradle to
Cradle require that the product is fully assessed and optimized. Optimization here refers
to the product being free of risk from exposure to Carcinogens, Mutagens or
Reproductive Toxicants (or CMRs), which are particularly problematic chemicals.
Cradle to Cradle is very different from the other two programs described as it neither
requires disclosure of product content, nor is the standard itself fully transparent.
According to Kokai (2014) the standard was initially “proprietary and inscrutable,”
though standard details have been revealed further over time, and the methods are
available for public review. Use of a third party to gather information from the supply
chain often allows manufacturers to maintain the confidentiality of product makeup or
intellectual property. This may attract manufacturers who are less comfortable with

25
ingredient or hazard disclosure, or have a more proprietary supply chain, but who still
want to engage with material health considerations for their product. Cradle to Cradle is
also one of the most expensive material health programs. The multi-attribute, third party
assessment of the product means that the certification cannot be carried out in-house.
Cradle to Cradle began awarding Material Health Certificates in 2014, which look at
only the material health portion of C2C certification rather than all 5 categories, in an
effort to engage manufacturers who might not be ready to pursue the whole certification.

2.9

Program Approaches

Each of the three programs studied in this research have very different program attributes.
However, these programs are all being used as a pathway for product selection for green
building programs.
One way to illustrate the differences between the three programs is by representing them
along a material health assessment continuum. In figure 2.8, Inventory refers to
determination of product content; Screen refers to cross-referencing ingredients against
Restricted Substances Lists (RSLs); Assess refers to assessment of all product ingredients
by looking at ingredients based on a number of hazard endpoints; Optimize refers to
required ‘improvement’ of products—specifically, that products be free of certain
problematic materials or free of risk of exposure from those materials.

26
Figure 2.8. Harmonization Pathway. Continuum representing the different functions of
the different voluntary material health programs (Adapted from Heine et al., 20120.
This representation makes clear that Cradle to Cradle is the only program that requires
higher levels of product assessment. However, the graphic does not look at the programs
more broadly. Figure 2.9 attempts to represent each program based on a larger set of
program attributes.
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Figure 2.9. Program Attributes of HPD, Declare and C2C relevant to the research.

2.10 Barriers to Gathering Information from the Supply Chain
Each of the programs described previously require manufacturers to gather information
from their supply chains. Depending on the vertical integration of a company, the nature
of products and complexity of the supply chain, this can be fairly straightforward, or
incredibly complex and difficult. This struggle to gather information from one’s supply
chain has been studied both in the US and EU for a number of types of products. In the
EU, a number of studies have looked at the introduction of REACH regulation and how it
is affecting manufacturers.
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Scruggs (2011) interviewed twenty consumer product companies from both the U.S. and
EU in order to better understand information challenges faced by these companies in
attempting to product safer products. The research was conducted in 2009 when REACH
regulation was relatively new and had not had much impact yet on the regulation of
chemicals in Europe in order to determine what barriers companies face in trying to
obtain information from their supply chain. The main barriers to obtaining chemical
information were as follows:
•

Trouble finding reliable sources of information on chemicals used in products

•

Data is often unclear or conflicting (i.e. risk may be different at chemical level
than when it is incorporated into a product)

•

Difficulty of identifying appropriate chemical substitutes in order to avoid
regrettable substitutions

•

Scarcity of data on ecotoxicology, nanotechnology and endocrine disruption

•

Trade secrets and confidentiality claims made by producers and manufacturers

•

Communication and information flow through complex, global supply chains can
be difficult and time consuming

Lack of routine information about chemical use and identity was a large barrier for
manufacturers. Each manufacturer had developed their own strategy for attempting to
combat these issues and create safer products. The most mentioned actions by the
downstream manufacturers included:
•

Developing restricted substance lists (RSLs)

•

Phasing out chemicals/products

•

Working with suppliers and

•

Developing a chemicals database

Most of their approaches focused around avoidance of particular chemicals, rather than
requiring full disclosure. While useful as models, these individual and unique approaches
require a significant amount of “reinventing the wheel”, where a standardized approach
would perhaps allow for more efficient use of time and resources and more
comprehensive protection for consumers (Scruggs, 2011).
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2.11 Barriers to Communicating Ingredient and Hazard Information
A wide variety of stakeholders are requesting information from supply chains. A number
of studies have emphasized the importance of considering who the request comes from,
and what level an depth of information is appropriate to communicate to that stakeholder
(Fransson et al., 2013; Fransson & Molander, 2012; Kogg & Thidell, 2010). Information
about chemicals in products often needs to be different depending on which stakeholder
needs to interpret it (Kogg & Thidell, 2010). Chemical and hazard information may be
useful to one trained or educated in these areas, but perhaps is not useful, and even
problematic, when provided to the layman.
Fransson et al. (2013) used a case study exploratory approach to study the flows of
chemical risk information in the consumer paint product chain. Safety Data Sheets (SDSs)
were found to be the main tool for communication of chemical risk downstream in the
product chain. In Europe SDSs are required for substances that “meet criteria for
classification as hazardous to human health or the environment.”
In particular, the study highlighted “the need for evaluation of how chemical risk
information is used in different contexts and the importance of directing the right
information at the right target group” (Fransson et al., 2013). SDSs are used for
communication between many different stakeholder groups with very different
knowledge bases (i.e. toxicologists and factory workers). Therefore documents useful to
some stakeholders may be burdensome for others and act as a barrier to decision-making.
The authors concluded that only the most necessary information should be communicated
to certain parties, such as simplified risk information to installers.
This opens the question of the format and extent of product information pertaining to
hazard and risk. Though more information about product content is undoubtedly needed,
there remains the question of how much information, what type of information, and who
should receive what. If a product can be deemed safe by third party assessors that better
understand the regulatory demands and toxicological implications of chemicals and
products, is a lack of transparency in that situation worse, or better than receiving a list of
the raw chemicals used in a product? To rephrase this: how important is transparency—
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defined in this research as ingredient and hazard disclosure—in trying to achieve
healthier products?

2.12 Qualitative Research
Originally used solely in the social sciences, qualitative research methods are now
employed across a broad range of research areas. Where quantitative research looks for
“causal determination, prediction, and generalization of findings”, qualitative research
goes in search of “illumination, understanding, and extrapolation to similar situations”
(Golafshani, 2003). Qualitative studies are able to recognize and articulate “the
complexity of a situation” without trying to distill events (Creswell, 2009, p. 4). This type
of research allows for emerging questions and more flexible procedures.
•

Natural setting: data is collected in the field rather than in contrived environments

•

Researcher as key instrument: the experience of the author collecting data
throughout the study is often central to the findings, as opposed to studies that
rely on tools and instruments of data collection defined by others.

•

Multiple sources of data: rather than relying on one source of information, the
researcher often combines surveys or interviews with observations or documents,
and analyzing those sources as a whole.

•

Inductive data analysis: raw data is gathered from multiple sources and organized
and analyzed to slowly build up patterns and themes.

•

Participant’s meanings: the researcher tries to avoid only bringing their
interpretation to the research, and instead try to focus on interpreting what the
participants see as issues.

•

Emergent design: because qualitative research is exploratory in nature, plans and
phases of the research process may change over time.
2.12.1 Interviews

Open-ended interviews allow the research an in-depth view into a participant’s
experiences and perspectives surrounding a particular topic. Turner (2010) describes a
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few forms of interview design commonly used. These are the a) informal conversational
interview b) general interview guide approach, and c) standardized open-ended interview.
As the name suggests, the informal conversational interview is the most free-flowing and
spontaneous. In this type of interview, the researcher does not have predefined questions
and relies almost entirely on interaction with the participant to guide the conversation.
The last method, the standardized open-ended interview is very structured in comparison
to the other types. Identical questions are used to allow for greater consistency and
comparability between the different interviews.
The general interview guide approach, which uses pre-defined questions and topics, is
most appropriate for this study. The researcher has the flexibility to probe deeper in
certain areas or ask follow-up questions based on the content of the responses. Follow-up
questions or prompts may be crucial in any type of interview, as participants may
misinterpret a question, choose to answer the question in a different way, or may in fact
answer a question that the researcher had planned to ask later. Flexibility is important in
order to gather the information necessary to the research. This approach can allow
tailoring of an interview to the participant and context; however, its relative success lies
in the researcher’s ability to gather data on relatively consistent topics.
2.12.2 Thematic Content Analysis
Thematic content analysis is often most appropriate when particularly theories on a
subject are limited, as is the scientific literature. In this type of analysis, the researcher
dives into the raw data, generally the interview transcript, and through repeated and
active reading, forming codes and patterns which are built into themes ultimately (Braun
& Clarke, 2006).
Thematic analysis is appropriate to reflect the rich and nuanced data produced in
qualitative research. Braun & Clarke (2006) argued that the analysis should be a method
in its own right rather than considered a subset within a larger method. They warned
against the description of “emerging themes” which gives the impression that the
researcher is a passive participant in the identification of themes, where this is often far
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form the reality. Researchers are active and deeply embedded in their role of studying,
grouping, and analyzing data.
Braun & Clarke (2006) describe six steps to conducting thematic analysis, though they
emphasize the flexibility of the data analysis methodology overall as an advantage of this
process.
1. Familiarize yourself with the data
2. Generate initial codes
3. Search for themes
4. Review themes
5. Define and name themes
6. Produce the report
Braun & Clarke define a ‘theme’ as that which “captures something important about the
data in relation to the research question, and represents some level of patterned response
or meaning within the data set” (Braun & Clarke, 2006). However, ultimately this
determination cannot necessarily be quantified (i.e. number of mentions) or even defined
qualitatively across studies (i.e. which topics are most important), therefore the judgment
of the researcher is really the ultimate determinant of what becomes a theme.

2.13 Reliability and Validity in Qualitative Research
In qualitative research, both the data collection materials and the researcher act as the
‘instruments’. Addressing reliability and validity in qualitative research is important to
instill confidence in the results of a study. Reliability refers to the consistency of
constancy of an instrument, or “the degree of consistency or dependability with which an
instrument measures the attribute it is designed to measure” (Long & Johnson, 2000).
Definitions found by Long & Johnson (2000) “all relate to confidence in data collection”
(p. 30).
•

Stability: does asking the same questions at the same time produce consistent
answers?
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•

Consistency: within a single interview does the respondent’s answer remain the
same?

•

Equivalence: asking the same question a few different ways

Validity is defined as “the determination of whether a measurement instrument actually
measures what it is purported to measure’” (Long & Johnson, 2000, p. 31). Three main
aspects of research are generally considered in relation to validity: content validity,
criterion-related validity and construct validity.”
•

Content validity “refers to the degree to which the entirety of the phenomenon
under investigation is addressed”

•

Criterion-related validity: “compare the instrument and findings with an
established standard to determine correlation between measured performance and
actual performance.

•

Construct validity: “consideration of the proximity of the instrument to eh
construct in question.”

Qualitative research often also employs ‘triangulation’ as a method for testing and
improving the reliability and validity of a study. Triangulation is used to limit bias by
combining different methods. For example, different types of methods or data can be
used to show that both are pointing to the same answer. This can include the use of both
qualitative and quantitative approaches to a study (Golafshani, 2003).
Long and Johnson (2000) outline some means by which to establish rigor in qualitative
research:
1. Self-description and reflective journal - by reflecting on one’s own beliefs and
opinions, the researcher makes their narrative explicit “rather than engaging in
futile attempts to eliminate the effects of the researcher” (p. 33)
2. Respondent validation (member check) - findings are checked with members of
the studied group. However, relying on solely participant opinion to validate a
study is not enough, as the memory of a participant may not be reliable, and
opinions may change with time.
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3. Prolonged involvement and persistent observation - spending more time in the
research environment may allow for “emerging concepts to develop and for
potential implications to be recognized” (p. 34)
4. Peer debriefing - “exploring one’s analysis and conclusions to a colleague or
another peer on a continuous basis” (p. 34)

2.14 Chapter Summary
This chapter explored the issues with US federal chemical regulation and how its gaps
put human and environmental interests at risk. Engagement with voluntary material
health programs was discussed as a method for addressing issues of understanding
content inventory and making better chemical, material and product choices. The main
material health programs studied in this current research were described. Previous
research on the motivation for engagement around gathering chemical information was
discussed as was research on the barriers to gathering information from supply chains.
The use of qualitative methods in gathering complex, nuanced information in exploratory
research was discussed.
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CHAPTER 3. METHODOLOGY

3.1

Introduction to the Methodology

Demand for transparency and disclosure under voluntary material health programs is
being driven largely by consumer demand, regulation, and green building standards
(Lowell Center for Sustainable Production, 2008). This research focuses largely on the
incorporation of material health programs into green building standards. It strives to
understand how they are being used, and what lies in the way of further adoption. Final
manufacturers are the primary stakeholders in supply chains interfacing with these
programs and grappling with these issues. Understanding their perspective and
interpretation may provide greater insight into the effectiveness of these programs in
decreasing the US chemical ‘data’ gap. The aim of this study was to investigate how
manufacturers are grappling with requests for product ingredient and hazard disclosure,
how they are interpreting the call for transparency around material health in the building
product industry, and what the barriers are to delivering on these demands.
The concept of ingredient and hazard transparency is being implemented across a number
of different industries, the definition and application of which will likely be different for
each industry. The current research sought to contribute to what will surely be an ongoing
discussion and reshaping of the concept of transparency, material health and green
chemistry in the building industry by presenting the manufacturer perspective on these
issues. Architects are designing green buildings and so their voice of demand is often
heard, with manufacturers seemingly on the defensive. This study is an effort to give a
voice to those manufacturers and further open up the conversation between supply and
demand to determine where there is common ground.
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This chapter presents the methodology used in the study, identifies the population and
sample, describes the tools used for data collection and data analysis techniques, and
finally discusses procedures for checking both the reliability and validity of the results.

3.2

Research Design

Inadequate chemical regulatory measures in the U.S. have resulted in a healthy materials
movement that relies heavily on voluntary measures to incentivize content disclosure and
product assessment (Waage et al., 2005). In the building products industry, these
programs, and the incentive to participate in them, are closely linked to the green building
movement. This research centers on the perspectives of U.S. building product
manufacturers perspective on material health and transparency, with the goal of better
understanding how they interpret these concepts and how they are acting on them. It also
looks to outline the broad barriers to further transparency, disclosure and ultimately a
healthier materials economy.
Due to the exploratory nature of this study, the investigation of material health evaluation
programs is by no means exhaustive. Many chemical information databases, material
health programs and chemical identification systems exist beyond the three programs
studied in this research. All of these will take a different approach to the issue of material.
The sampled companies have been highly, and intentionally, delimited by the researcher
to include those programs that have a) been accepted as an acceptable compliance path
for LEEDv4 building product disclosure and optimization credit and b) as perceived by
the industry professionals as the most widely used and relevant to the conversation.
The Health Product Declaration (HPD), Declare, and Cradle to Cradle (C2C) are three
programs specified as a pathway to achieving the LEEDv4 disclosure and optimization
credit. Other programs were touched upon during the research due to their prevalence in
certain industries (i.e. the Level program for the furniture industry) or their incorporation
in other programs (GreenScreen and the GreenScreen List Translator are used to obtain
hazard ratings for chemicals in some programs).
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This study used primarily qualitative research methods, though it also employed minor
quantitative techniques to aid in analyzing survey data. The study was conducted over
two stages.
1. Interviews – semi-structured open-ended interviews were held with
manufacturers after gathering expert input and refining the research instruments.
Individuals in product sustainability (or similar) positions in manufacturing
companies with awareness of all four main material health programs were invited
to participate in semi-structured open-ended interviews in order to have an indepth discussion about the process of program compliance and the role of
transparency in their company and in the industry as a whole.
2. Surveys – A small pilot survey was sent to interview participants who expressed
particular interest in the study. Manufacturers were invited to take the survey and
provide feedback either at the end of the survey or by email. Based on their input,
some survey questions were amended. Full survey distribution took place after the
pilot survey. Surveys distributed to a larger sample similar in nature to the
interview participants.
The research process is further illustrated in figure 3.1.
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Conduct Review of the
Literature

Design Preliminary Survey
and Interview Guides

Administer Pilot Survey

Gather Expert Input on
Research Topic and Data
Collection Materials

Revise survey and
Administer Final Survey

Revise Research Materials
Based on Feedback

Collect Survey Results

Conduct Interviews

Use Survey Report to
Analyze Qualitative Data

Transcribe interview Data

Distill Interview Data into
Themes + Subcategories

Use Interview data to inform
Survey Questions

Consider Interview and
Survey Results to Answer to
Research Questions and
Draw General Conclusions

Validate Conclusions with
Material Health Experts

Figure 3.1 Flowchart of Research Process

3.3

Population and Sample

This study was concerned with the perspectives of manufacturers of building products
who were based in the US. Rather than looking to obtain a sample representative of the
full population of building product manufacturers in the U.S., purposeful sampling of
participants was used. Selecting the participants based on key attributes suits the nature of
qualitative research. Rather than trying to look for a random, representative sample, the
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researcher tries to “purposefully select participants or sites (or documents or visual
material) that will best help the researcher understand the problem and the research
question.” (Creswell, 2009).
In looking to understand how transparency is being interpreted in the building supply
chain, final manufacturers were determined to be the most suitable subjects. Final
manufacturers sit at a pivotal point at the end of the supply chain. They are often a first
point of contact for architects requesting information about a product and, at this point,
are in charge of gathering and synthesizing chemical data from within their product’s
entire supply chain. Their perspective, therefore, on the programs, the process of
gathering the information, and on the nature of transparency, is informed by stakeholder
relationships on both the supply and demand sides, and they are often ultimately
responsible for labeling/certification of products and/or compliance with standards. Also,
being consumer-facing, they are more likely to be easily reachable and open to a
conversation, and would have directly interfaced with the issues looked at in this study.
Final manufacturers are defined in this the current research as consumer-facing
manufacturers that control the “final point of fabrication or manufacture of an assembly
or building material” (LBC, 2014). These manufacturers supplied the primary population
for this study. However, suppliers and manufacturers of chemicals were ultimately not
excluded from participation. Though their perspective is likely to differ from
manufacturers that are selling products directly to consumers, many large suppliers may
also sell final products in addition to chemicals and components. What is more, previous
research has identified the inability to gather information from suppliers as a major
barrier to further material health disclosure (Fransson, Brunklaus, & Molander, 2013;
Lowell Center for Sustainable Production, 2009; Scruggs & Ortolano, 2011). Therefore, a
glimpse into their perspective and how it may, or may not, differ from the more
consumer-facing manufacturers was of interest in gathering the fuller picture.
Overall the sample was selected by identifying those manufacturers that have
differentiated themselves through their involvement with the different voluntary material
health programs. This was because they will have the best insight into how the programs
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work and what the barriers to compliance and adoption of principles of material health
and disclosure are. Another reason for studying the leaders in the material health field is
that they are the best indicators of where the industry as a whole will head. The Roger’s
Curve of Innovation Adoption (Figure 3.1) shows the importance of approaching
innovators and early adopters first, rather than focusing on the majority or on the laggards.
Working to lower the biggest barriers faced by the leading edge of the curve may
contribute to reaching a critical mass of adoption faster. This research looks to provide
insight into what manufacturers believe these barriers are and how to lower them, and it
intends to provide a foundation for future research that delves deeper into the identified
barriers.

Figure 3.2. Roger’s Curve of Innovation Adoption (Rogers, 2003).

3.3.1

Interview Sample

Participants for the interviews were employees within building product manufacturing
companies, generally at a senior sustainability level, who have played a role in interacting
with the main material health evaluation programs studied in this research. Generally,
participants involved in product stewardship and sustainability and had a strong
knowledge of the product content and the attributes of each material health evaluation
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program. Knowledge of the main material health evaluation programs studied in this
research was a prerequisite for participation, although the manufacturer only had to have
engaged with a minimum of one of the programs. Initial participants by were selected
consulting with individuals working within the material health programs and from
leading architects and manufacturers heavily engaged in issues of material health. Each
participant was contacted by email with details about the study and offered the
opportunity to participate as an interview subject. Snowball sampling was used to obtain
further participants, as participants offered up other potential manufacturers to speak with.
All participants willing to participate in the 45-60 minute interview made up the sample.

3.3.2

Survey Sample

Survey participants were pulled from a similar population as were the interviewees.
Participants were sustainability directors or product stewardship employees at U.S.
manufacturing companies with familiarity with issues of material health and transparency.
Potential participants were identified through looking at the websites of the different
material health programs studied and identifying manufacturers who appeared to be
involved in at least two of the programs. The sample represented a diversity of product
types. Specific contacts were identified through interaction with people working at
material health programs, making it easier to deliver the survey to the right person at the
company.

3.4

Data Collection

This study used human subjects to collect qualitative data. The study was conducted on
the condition of anonymity, therefore recordings were destroyed after transcriptions of
audio were made and identifiers were created for participants so as to remove identifiable
information in the transcripts. As described above, the research was conducted in three
main parts, beginning with interviews and followed by the distribution of first a pilot
survey, and then a full online survey.
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3.4.1

Interview Data Collection

Interviews are rich in data and are able to provide greater insight into the complexity of
material health issues and transparency. Semi-structured, open-ended interviews were
conducted with individuals in senior product sustainability, or similar, positions at US
manufacturing companies.
Participants were contacted via email. Participants who agreed to be interviewed
as part of the study were asked to commit 45 minutes – 1 hour to the interview process.
Interviews were conducted over the phone and WebEx was used to record the phone calls
to allow for playback and transcription at a later time. Recording allowed the interviewer
to take handwritten “strategic and focused notes” during the interview. According to
Patton (2002), these notes serve the interviewer in a number of ways, including:
1. Helping the interviewer create new questions based on the conversation
2. Allowing the researcher to use insight from an interview for the next interview
before transcribing all of the text
3. Making later analysis easier by highlighting key points and determining when a
point of interest was made
4. Acting as a data backup in case of technology malfunction.
Marginal notes were also taken by the researcher during the phone interview to record
researcher observations of participant responses, and any points of particular interest.
Raw data was then transcribed into Microsoft Word soon after the interview was
complete. Recordings were deleted once transcription was complete.
3.4.2 Survey Data Collection
Outreach to survey participants was also conducted using email. Emails clearly identified
the intent of the researcher, the purpose of the study, and the researcher’s position within
their university.
Survey content was informed by research by Scruggs (2015) on manufacturer potential
for REACH compliance. A small pilot test of the survey materials was also carried out.
The survey was presented to manufacturers who participated in the interviews and
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expressed interest in the research. This was done to determine whether the length, format
and content of the surveys were appropriate. Qualtrics was used to distribute the surveys,
collect survey data, and conduct a primary analysis of the results. The survey was
designed to take under 25 minutes to complete.

3.5

Data Analysis

Interviews:
Analyzing raw interview data relies on the recognition of patterns, and organization of
codes into themes. (Braun & Clarke, 2006). Marginal notes taken during the interview
were used to provide more context regarding the researcher’s observations of participant
responses and points of interest, in order to add depth to the data available for analysis.
Each interview was 45 minutes to 60 minutes long. Recorded interviews were transcribed
using Microsoft Word. Each interview produced approximately 8 to 12 pages of raw data.
Interviews were collected over a period of approximately two months. During this time, a
separate document was used by the researcher as a reflective journal, allowing for
externalization of observations and opinions (Long & Johnson, 2000). Notes were added
to and rewritten in an iterative manner, allowing the researcher to note emerging themes
and refine future interviews based on previous interview and informal conversations.
Though interview questions were outlined prior to beginning this research, once the
interviews began it became clear fairly quickly that those questions needed to adapt to
each conversation, and would evolve over time (general interview guide can be found in
Appendix A). A more inductive approach to analysis was used, in which the research
questions ultimately evolved alongside the coding process.
Thematic analysis was used to distill and organize the data. The process followed Braun
& Clarke’s (2006) description of thematic analysis. First, once all of the interviews were
complete, the researcher read through all of the interviews from beginning to end,
allowing them to view the narratives as a whole (Braun & Clarke, 2006). Next, initial
codes were generated in order to assign “tags or labels” to the raw data. Due to the
amount of data and breadth of the responses, the researcher incorporated two additional
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distillations of the data. The original codes were distilled into 1-2 page lists of categories
to make the number of items more manageable. Those categories were then linked to
construct the overarching themes. Themes were reviewed and reorganized as necessary,
then titled and defined. Themes generally incorporated a large number of perspectives
thus ‘subcategories’ were used to represent key perspectives within a larger theme.
Interpretive analysis of the themes was used to describe the results obtained.
Surveys:
Surveys contained a series of questions with varying response formats (Yes/No, multiple
choice, and Likert style scales) as well as some open-ended questions where respondents
had the opportunity to define a term or elaborate on their answers. Preliminary data
analysis took place in Qualtrics. Where appropriate, tables or graphs were used to
represent survey results. The survey results have been used to supplement themes found
among the interview results, however, the survey is considered to be more of a model for
future work than standalone results.

3.6

Reliability and Validity

Expert engagement through a series of phone calls with architects, manufacturers, and
material health program designers, was used to first validate the research scope, as well
as the survey and interview format, content and scope, prior to beginning the research.
This allowed the researcher to further confirm the relevance of the study, and determine
the appropriate format and length of surveys and interviews in order to avoid participant
fatigue or bias.
Triangulation was employed in this study by investigating the same topic in both surveys
and interviews. Surveys also combined qualitative and quantitative methods.
As per the recommendations of Golafshani (2003), a reflective journal, peer debriefing
and some respondent validation were all methods used by the researcher. The third
recommendation, prolonged involvement, was not an option for this type of study, nor
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within the researcher’s timeline. The results of this current research were also presented
to an expert involved in the healthy materials movement.
Surveys
As the survey was created for this research, a pilot survey was used to check the
methodology and content of the survey before full distribution. The pilot survey was
administered to participants in the same way the full survey would be. Subjects were
asked to take the survey and provide feedback on the questions, and the overall survey
content. The time taken by participants to complete the survey was also taken into
account and found to be reasonable. Questions were reworded as necessary where
participants identified confusion or issues with rating scale.

3.7

Summary

This chapter described the specific methodology used to conduct this qualitative research.
Development and implementation of the research tools, namely interviews and surveys,
were described. Sampling methods, data collection and use of thematic analysis were
discussed. Additionally, methods by which the researcher validated the research
methodology and outcomes were outlined.
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CHAPTER 4. RESULTS

4.1

Introduction

This chapter guides the reader through the results obtained in data collection. Deviations
from the intended methodology are explained, and the specific methodology of analysis
is described in-depth. The results of the interviews and overarching themes obtained are
then presented, followed by an analysis of the survey data.

4.2

Methodology Deviations

Methodological adjustments are a common course of action in exploratory, qualitative
research (Creswell, 2009). Interview questions, although based around the same general
interview guide, were adapted in each interview to recognize the varied experiences and
perspectives of participants. Flexibility was important in order to allow for examination
of issues most important to interviewees and the creation of more personal interviews
(Turner, 2010). It quickly became clear that the very specific interactions with material
health programs or methods of data communication were highly varied and companydependent. Those types of questions were therefore eschewed in favor of questions that
explored perceived barriers to material health considerations in the interviewee’s industry,
and their perspectives on larger industry issues.
This research originally proposed to distribute the survey to the approximately 280
manufacturers represented in the Pharos Project, which is a database used for identifying
health hazards associated with products and aggregates information and certifications
from a number of other programs. During the course of this research, it became clear that
getting up-to-date manufacturer contact information for survey distribution would be
challenging. Instead, contact information for 76 manufacturers engaged with material

46
health programs were identified through leveraging industry contacts and formed the
outreach sample.
4.3

Use of Expert Input

In order to gauge industry interest in the research and to help shape the direction and
scope of inquiry, five experts in the field of building products and material health were
consulted prior to beginning the interview and survey processes. This outreach was done
in collaboration with a master’s student at UC Berkeley studying similar issues of
transparency and disclosure from the perspectives of architects rather than manufacturers.
Participants were sent the research objectives, a draft interview guide, and some
discussion questions.
The goal was to speak with representatives from a few stakeholder groups in the building
product industry. Therefore, a manufacturer and an architect, both possessing significant
working knowledge of material health evaluation programs were contacted by phone. It
was also critical to speak with the people developing the material health programs studied
by this research. Therefore, conversations were held with a representative from each
program to understand the philosophy behind the program, the motivation of their work,
program requirements, and how they each fit into the marketplace
The experts’ input was used to delimit the number and types of programs studied in this
research. It was determined that GreenScreen for Safer Chemicals should not be studied
alongside HPD, C2C and Declare because GreenScreen is considered more of an internal,
ingredient-level toxicology assessment, rather than a consumer-facing product-level
assessment or standard. GreenScreen was nonetheless touched upon in some
conversations and in the survey, due to its role in the field of ingredient assessment and
toxicology, and because of it is used as a tool for screening ingredients within other
standards such as the HPD. This work also confirmed significant industry interest in the
issues of transparency and disclosure.
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4.4

Interview Sample

Experts contacted in preliminary research approved the use of snowball sampling for the
interviews, and they suggested the first round of 5 interviewees based on the research
parameters and their knowledge of the main companies working on these issues. From
there, snowball sampling was used to reach the other 7 participants. Ultimately, 20
invitations to participate in the research interviews were sent by email, and 16 responses
were received. Out of these, 12 interviews were ultimately conducted.
Participants’ companies represented a number of different sectors in the building
products industry. The companies were also positioned at different places in the supply
chain. Some manufacturers were downstream producers of final products ready for sale
to consumers (hereon described as final manufacturers); other manufacturers operated
upstream in the supply chain, manufacturing inputs such as coatings and chemicals
(suppliers); many operated at both levels. Table 4.2 shows the breakdown of participant
company sectors and participant roles.
Table 4.2
Participant company role, and manufacturer sector by interview
#
1

Sector Description
Paints and finishes

Participant Role
Technical Sales Manager

2

Carpet

Director of Sustainability

3

Architectural products

SVP of Sustainability; Sustainability Coordinator

4

Furniture + Office products

Global Environmental Sustainability

5

Exterior building products
(shading)

Director of Sales and Marketing, Sustainability

6

Chemical and coatings (S)*

Global Product Stewardship

7
8

Insulated panels
Furniture + Office products

Director of Education and Sustainability
Head of Sustainability

9

Chemicals + Coatings (S)*

Sustainability and Education

10

Office furniture

Sustainability Strategy

11

Carpet

Sustainability Leader

12

Doors and Locks

Director of Sustainability
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Participant’s companies had demonstrated engagement with one or more of the voluntary
material health programs focused on in this research. This was demonstrated either
through formally publishing the output of the program engagement, by participating in
pilot processes for the programs, or through representation on the program’s website.
Interview participants were familiar with all three programs (HPD, C2C, and Declare),
and had formally or informally participated in at least one of programs. Participant roles
ranged from technical sales manager, to toxicologist, to SVP of Sustainability. All had
directly or indirectly worked with the material health evaluation programs and
information gathering process within their company and were therefore the most, or one
of the most, qualified individuals at their company to participate in the study.
Types of manufacturers interviewed did not represent all sectors of the industry as there
is a wide range of products produced for the built environment. Also, some sectors are
better represented by their engagement with these programs than others. For example, the
leading carpet companies are all heavily involved in these efforts.
The sample was composed of 3 manufacturers who produce paints and coatings, 2 carpet
and flooring, 3 furniture and office products, 1 exterior building product company, 1
insulated panel company, and 1 door and lock company. It should be noted that two of
the coating companies, participants 6 and 9, generally act more as suppliers to other
companies than as final manufacturers, though they may also be consumer-facing at
times. This distinction was taken into consideration in the data analysis for this research.
Based on working knowledge of the industry and interview results, the position of a
company in the supply chain and the nature of products and manufacturing process are
likely to influence a company’s perspectives on transparency and disclosure. Some of the
benefits, or barriers, to program participation, were certainly influenced by the types of
products made, along with a number of other factors.

4.5

Interview Analysis

As discussed earlier, the line of questioning used in the interviews evolved as the
research progressed, and was dependent on the content of each interview. Therefore, it is
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important to address the general line of questioning used by the researcher. Participants
were asked about the following areas:
•

Background on their company’s role in the supply chain and the participant’s
involvement in issues around material health

•

Company and participant involvement with voluntary material health programs

•

Manufacturer process for gathering information from their supply chain

•

Aspects of material health they felt were most important to communicate to their
consumers about their products

•

Barriers they face to further disclosure of their product content

•

Relative importance of transparency in leading to a healthy materials market.

The use of a general interview guide approach built flexibility into the process and
allowed for data that was very rich in its content. While conversations varied in specific
content, they invariably provided useful information around the central issues of
transparency and material health in the building products industry. This approach also
allowed the researcher to probe unanticipated topics brought up by the participant when
appropriate. The researcher elected to qualitatively analyze the data in order to tease out
broad themes and experienced realities within the healthy materials economy. Given the
diversity of responses received and the breadth of their content, thematic analysis offered
a flexible approach to distillation of the data that preserved the context and complexity of
the issues.

4.6

Interview Themes

Interviewee’s perspectives were influenced by both their company’s approach to material
health and disclosure issues, and also by their own personal views. Factors potentially
affecting their perspective included, but were certainly not limited to:
•

Company mission

•

Company size
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•

Industry sector (type of products affects materials used, types of suppliers,
amount of intellectual property, etc.)

•

Company position in supply chain (e.g. consumer-facing downstream vs.
upstream suppliers)

•

Company’s consumer demand for disclosure and transparency

•

Material health program participation and relative understanding of each program
(C2C, HPD, Declare, or other programs)

•

Relative internal/external success interacting with programs

•

Supply chain nature, structure and complexity

•

Amount of internal or upstream proprietary information

•

Interviewee’s personal interests/beliefs as an employee or as a consumer

With these factors in mind, analysis of interviewee responses identified six overarching
themes. Considering the range of companies and product types in this study, these factors
led to very varied perspectives within each theme. Therefore, where appropriate,
subcategories are used to break down the central issues raised. While different
participants often presented diametrically opposite perspectives to each other within a
theme, issues discussed in the interviews were ultimately very consistent from interview
to interview. Manufacturers of very different products raised many of the same issues,
even if their stance on a particular issue was different. These themes are key to
understanding the potential of transparency and disclosure, frustrations and barriers in
engagement, and opportunities for progress and improvement in the future.
The following section each overarching theme and its subcategories, occasionally using
quotes from the raw text for support. Quotes or issues are attributed to specific interviews
using superscript numbers. The five themes and their associated subcategories identified
from the interviews are as follows:
1. Some content transparency in the industry is overdue
2. There is more information than education
a. Supplier education can improve data quality and quantity
b. Consumer education can increase demand and improve specification
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3. Hazard vs. Risk is an important, but controversial topic
a. Restricted Substances Lists are scalable, but simplistic
b. Hazard ratings lack context
c. Risk and exposure assessment adds context, but is imperfect
4. Lack of standardization is stymying progress
a. Standardizing Content Inventory
b. Standardizing Screening
c. Standardizing Chemical Assessment and Optimization Efforts
5. Prioritization
4.6.1

Some Content Transparency is Overdue

Interviewees repeatedly pointed out how new the issue of transparency and disclosure are
in the building industry. Product ingredient and hazard transparency were described as
being in their ‘infancy’. At the same time, participant responses, along with the growth in
adoption of disclosure standards such as Declare and HPD in the past few years point to
increasing demand for, and industry comfort with, the concept of transparency. Even the
Cradle to Cradle standard, which itself was not founded on the principles of disclosure
and transparency, was described as moving towards a more transparent model.
All participants agreed that greater transparency and disclosure around material health
was overdue in the building products industry—“I think it’s an important part of the
evolution of our industry, to kind of clean ourselves up a bit”5. Opinions about the nature
and extent of that disclosure varied widely among all participants.
Some manufacturers felt that transparency was the foundation of a healthier materials
market, because “as long as you can hide behind not being fully transparent, there will be
no pressure to change.”5 Others held a more moderate view: that transparency alone is
enough to fight for, but should not be considered in isolation. Yet others expressed
opinions closer to “transparency on its own doesn’t do anything.”8 Due to the complexity
of chemistry, the life cycle of building products, and the difficulty of interpreting
ingredient and hazard output, solely listing the ingredients and/or hazards present in a
product for consumers to read is not necessarily enough information for an informed
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purchasing decision or enough incentive to spur manufacturing changes. Manufacturers
struggled more with the format and interpretation of that disclosure than the push to
disclose information:
We’ve changed out a couple of ingredients that we wouldn’t have changed
out had it not been for transparency – or we would have taken our sweet
time changing them out. It was difficult and it was expensive and we had
to change our formulation. But this is how our product is going to look in
these systems if we don’t change this out and this is the business we’re
probably going to lose out on. So on the whole this is a good thing…I’m
just saying that it’s pretty imperfect right now how we’re sussing how
healthy a material is.2
The distinction between disclosure and transparency was not clearly made in the proposal
for this research, nor in the interview guide. This distinction was very important to
manufacturers and therefore pointed out repeatedly. Disclosure was described as one
enactment of the principles of transparency, but the two terms are not interchangeable.
Although full disclosure of product content is sometimes touted as the ultimate
transparency, some manufacturers who were unable to participate in the programs this
way to due proprietary supply chain claims felt that in the absence of full public
disclosure they could still be transparent with their customers about the barriers to doing
so. If ingredient and hazard disclosure is the release of product information, transparency
is an honest, open dialogue about the nature of that disclosure.
The ability for peer review and conversations of comparison was generally considered a
positive result of the transparency movement. While some participants criticized the
existence of what they considered incomplete information presented self-disclosure
programs (HPD and Declare), the ability to review and criticize those labels openly
appeared to be recognition of the value of public disclosure. Some Declare labels have
expanded their lists of ingredients over time. Participants postulated that this may have
been because of pressure from competitors who pointed out inaccuracies2; it may be also
be due to better manufacturer and suppliers education and understanding of the
requirements of program and therefore the collection of more accurate and granular
information. As programs evolve, manufacturers and their supply chain become more
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sophisticated around disclosure. The pressure for accuracy is increasing, as is the ability
to release accurate information.
A few participants who struggle with full disclosure emphasized that the word
‘proprietary’ on a label doesn’t mean a manufacturer is necessarily hiding anything.
Rather, it often indicates the limits, or perceived limits, of what a manufacturer can
disclose about their own product, or what they can learn about their supplier’s products.
“We’re giving you as much info as we can. I think that’s still a cloudy area in the whole
transparency movement that has to be addressed or understood by people who are
looking at an HPD and really don’t know what they’re looking at except that they expect
to see the Colonel’s 11 herbs and spices.”1
As for the accuracy of disclosure, while there will certainly have been cases of
intentionally omitted or manipulated information to conceal issues with how a product
presents, manufacturers felt that at this point the majority of errors in self-disclosure
programs should be viewed as errors of omission, rather than commission12. It’s clear to
manufacturers, and to these program developers, that a lot of self-disclosed labels contain
inaccuracies, but this is not necessarily a manipulation and will often be due to lack of
accurate information or lack of clear understanding of requirements. Therefore, the aim
should be to move towards a future where what is required is clearly defined and clearly
understood. At that point, if information is missing, it is no longer just an accident or
different interpretation; when we get to that point, inaccuracies become errors of
commission.
Overall, each participant’s definition and perception of transparency was somewhat
different. Interviewee definitions of transparency are shown in Appendix C. The range of
definitions in this study, from twelve manufacturers already engaged with these programs,
helps to illustrate how difficult it may be to create an industry-wide interpretation and an
industry-wide standard for disclosure and transparency.
Each interviewee’s company was attempting to adapt company practices in order to
respond to the demand for further material health transparency. However, frustration was
clearly expressed at aiming at disparate, and often moving targets. The level and type of
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disclosure is different in each material health program, so it is sometimes difficult to
know which direction the market is moving in, and whether one is headed in the right
direction. At other times, one may feel that they are being pulled in the wrong direction
by consumer demand, because consumers may have an incomplete picture of what is
needed. The lack of cohesive definition can be difficult for manufacturers trying to
grapple with these issues while also balancing a huge number of other priorities and
product attributes. Certainly these definitions will continue to shift as the industry
continues to adapt, and as manufacturers become more comfortable with the concept of
disclosure and assessment.
4.6.2

More Information Than Education

In general, there was a strong perception from all participants that currently there is a
huge amount of material content and data being gathered, with little collective
understanding of how to interpret or use that information1,7,9. The relative utility of
collecting and disseminating that data was much debated by interviewees. The need for
more education around material health, transparency and disclosure, however, was
referred to in all 12 interviews. Generally, the intended recipients of that education were
divided into two subcategories: upstream to supplier, and downstream to consumers and
contractors.
4.6.2.1 Supplier Education
The interviewee with probably the most cooperative supply chain pointed out that they
were the anomaly in the industry. At this point in time they felt that “the chances of
getting information from your supply chain is slim; the chances of getting information
that is correct is rarer still”5.
This statement points to two perceived barriers to further transparency and disclosure:
quantity of data disclosed, and the quality of that data. Participants felt supplier education
would have served to lower both of these barriers. Continued supplier education has the
potential for two outcomes. First: to make suppliers more comfortable with the idea of
disclosure. The participants in this study are considered leaders in terms of engaging with
issues of material health, yet even for them suppliers were often unlikely to disclose at
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the level necessary for engaging with many of the programs studied in this research.
Participants described some suppliers as nervous that their consumers would switch
suppliers or give information to another supplier and cut them out; other suppliers were
uncomfortable with giving out their proprietary recipes to anyone8. Supply chains that are
resistant to disclosure are still the norm5, though participants generally agreed that supply
chains are becoming increasingly comfortable with the concept of transparency1. Clearly
communicating what information is needed, and why the final manufacturer needs it may
help suppliers to feel more comfortable with releasing more information.
Second, education may help suppliers to understand the specific data and disclosure
requirements, potentially improving the quality of the data released. The ease of
communication with suppliers and the ability to gather good upstream data was described
as crucial to further engagement with programs, and to the success of transparency as a
movement. Manufacturers took a range of approaches to obtaining better information. .
The staffing and capacity of the manufacturer, and the complexity of the supply chain
often affected the amount of control manufacturers felt they had over the quality of data
provided by their supply chain. Most were heavily involved in educating their suppliers
to the best of their abilities. One participant said they company had thus far actively
engaged 400 out of their 1200 suppliers4 around issues of transparency and disclosure.
Some manufacturers felt they could only do so much and had to trust the suppliers, or
their suppliers’ suppliers after that. A degree of uncertainty exists inherently in complex,
and even in simple, supply chains, which can only be minimized to a certain degree.
Other interviewees wanted greater assurance of the accuracy of data, and were going
back multiple tiers in their supply chains to gather information. They found that if they
merely trained suppliers to ask their suppliers for specific information, “it didn’t really
work because they would ask for the wrong thing and they would come back with huge
spreadsheets full of bad information. In the end we found it was a lot smoother if we
could do it.”8 The efficacy of this approach is highly variable between companies and
dependent on the size and complexity of supply chains and staffing capacity.
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4.6.3

Consumer Education

The need for consumer education around interpretation of transparency and disclosure
was the most prevalent of all issues raised in the interviews, regardless of a
manufacturer’s product types or position in the supply chain.
Participants were grappling with how their company can meet consumer demands to
gather and disclose information and be specified for projects, while a) balancing a real, or
perceived, need to hold some ingredient or hazard information proprietary, and b) making
sure their products were accurately (and of course, favorably) represented. Consumers are
generally unlikely to be able to adequately understand and interpret complex ingredient
and hazard information. Feeling that one’s consumers may be misinterpreting disclosed
information regarding product content and safety can be a significant disincentive to
disclose in the first place. The areas of consumer education needed as described by
interviewees was divided into two categories:
1. Understanding of the attributes and role of each program
Understanding the intention of each program and the type of information it gathers and
provides is very important. These three programs, despite the differences among them,
are all acceptable compliance paths for material health requirements of green building
programs such as for Building Product Disclosure and Optimization Credits within
LEEDv4. The reality is that there if often a “check the box” mentality by architects3,4,5
who have neither the time nor the expertise to adequately interpret the output of some
programs. Compliance with written requirements of green building certification programs
is often enough for an architect to specify a product without further research into the
product. Participants feared that the differences between the programs would not be
appreciated3,4,10; a Cradle to Cradle Gold certification might be held up as equivalent to a
Health Product Declaration, despite the former program being multi-attribute and
requiring ‘optimization’ of the product, and the latter a single-attribute disclosure and
communication tool. Each program serves its own purpose, and the importance of
multiple avenues of engagement was recognized as important by many interviewees.
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However, it remains important that consumers be educated on the role and intention of
each program so that demand drives positive change in products.
2. Encouraging more informed product selection through consumer education on
interpreting program output
Manufacturers were particularly concerned that consumers be able to interpret the actual
output of the program. For the programs studied in this research, the output ranges from
an overall product rating level (Cradle to Cradle) of bronze to platinum; to an ingredients
list with CASRNs listed (Declare), to an ingredients list where CASRNs are optional but
ingredient hazard ratings are required (HPD). Participants whose companies were
disclosing information through the HPD standard appeared to have the most concerns
about incorrect interpretation of their disclosure. Instead of being rewarded for
transparency through hazard disclosure, manufacturers were worried that consumers
might be scared off by the information disclosed.
This particular concern about disclosure interpretation itself could be manifested in two
ways. First, manufacturers felt some uneducated consumers were specifying a product for
a project merely based on a product’s engagement or compliance with one of the material
health programs, regardless of the results of that engagement (output)4,8,12. If HPDs were
being requested merely as an ‘exercise’ for manufacturers, or so that architects could
“check a box” for a building certification credit, rather than contributing to educated
decision-making, “they’re useless.” HPDs screen against a significant number of
authoritative hazard lists, but as a standardized communication tool their role is not to
ban the use of any chemicals, nor to provide a rating or measure of achievement for
material health for a product. Therefore, having them as an equivalent pathway for
selecting materials may be problematic as most consumers are unable to adequately
interpret an HPD. Put another way, two products—one very safely produced with
nontoxic materials, and one with a very poor toxicological profile—can both have an
HPD, and the consumer may not have the time or expertise to know the difference.
Conversely, a consumer may explicitly avoid a material based on the hazard ratings of
ingredients, without taking into account any product-level chemistry context, or

58
consideration of the life cycle of the materials. Flooding the consumer market with
complex information may actively deter consumers from purchasing products because
they cannot adequately interpret that information. For example, many ingredients that
present as problematic based solely on hazard ratings, may not actually exhibit these
issues in a product if they are bound to other ingredients or are found in a different form.
Interviewees shared their own anecdotes of consumer avoiding all products flagged as
having carcinogenic ingredients, regardless of the product context or use.
These educational issues can be major deterrents for manufacturers. Barriers to
determining what is in one’s product, and disclosing that information accurately in one or
more programs, are themselves significant. Manufacturers then present that information
to consumers in good faith that the public can correctly interpret it. When participants felt
their product was, or might be, rejected because of the format and level of information of
the standard output, and the level of education required to interpret the output, they
expressed reluctance to repeat the process.
4.6.4

Hazard vs. Risk is Important but Controversial

Chapter 2 introduced the terms hazard and risk and made an initial attempt to define them
within the context of the current research. Interviews revealed that a) the distinction
between hazard and risk is felt to be unclear in the industry and that b) the debate around
the use of hazard and/or risk to assess the relative safety of chemicals and products for
humans and the environment is central to the material health discussion, and one of the
fundamental disagreements in the building product industry. Participants were divided
over their view of the best approach. While none of the participants necessarily disagreed
that the use of risk and exposure assessments offered the most accurate representation of
a product’s risk to end users, their position on the issue of hazard vs. risk in practice
varied widely. There was also a clear tension between scalability of current material
health solutions and the accuracy of those scalable solutions.
4.6.4.1 Restricted Substances Lists
All three of the material health programs studied in this research, and likely the vast
majority of programs in existence, incorporate the concept of ingredient hazard as a
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measure of product safety to some degree. After inventory of product content is
accomplished, program requires some level of screening ingredients against a list, or a set
of lists, of “worst-in-class” chemicals. Declare and C2C require the absence of certain
chemicals to publish in the standard; Declare’s list is called the Red List, while C2C is
called a banned list. The HPD allows any product to participate, but highlights the
ingredient hazards on the standard. The use of ingredient hazard ratings as a determinant
of material health signals that some materials are inherently problematic and should be
avoided. One of the chemical suppliers interviewed, in particular, took disagreed with
this concept, saying “just because something has x or y in it—chemistry is complicated—
it doesn’t mean it’s bad, right?...Any chemical, depending on the situation, could be good
or bad.”9
RSLs were most closely associated with the Declare in the interviews. Declare does not
go beyond screening to require full assessment of ingredients or risk and exposure
(although context is taken into account with the use of temporary exceptions allowed for
particular applications of ingredients or products) where Cradle to Cradle does. In
addition, the Red List is the arbiter of whether or not a product can be used in an LBC
project.
The simplicity of the Red List approach as a material health tool in and of itself was
appreciated by some of the interviewees. RSLs provide clarity for manufacturers and
consumers when engaging with issues of material health in their absoluteness; judging
products based on the presence or absence of certain materials or chemicals. This method
of addressing material health is relatively a) easy to understand b) easy to communicate
up the supply chain c) easy to communicate to consumers and d) scalable across product
lines and for a whole company. With so many building product attributes to take into
account by manufacturers, and by the architects specifying products (Akadiri,
Olomolaiye, & Chinyio, 2013; Ogunkah & Yang, 2012), knowing what to avoid can be
clearer, cheaper and less time-consuming than a more in-depth, nuanced approach.
The simplicity and scalability of this approach is tempered by its lack of context, which is
a greater issue for some manufacturers than others. Despite an expressed desire for
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scalability at the supplier level, the outright ban of chemicals was of course, antithetical
to the chemical supplier’s interests9. Beyond just chemical suppliers, the sweeping
generalizations required by RSLs are problematic for manufacturers for a number of
reasons:
•

Misconception that RSLs capture all the ‘bad’ chemicals or materials: lists
vary widely, and may not yet include materials that will eventually be considered
problematic

•

Discrepancies between different lists: different governments, material health
programs, manufacturers, and even architects are creating their own RSLs. This
can mean a product looks ‘ok’ according to one list, but perhaps not with another,
often without understanding the reason for the difference.

•

Red List free doesn’t necessarily mean ‘good’: merely avoiding a particular set
of chemicals does not ensure the environmental and human “safety” of a product

•

Risk of regrettable substitutions: because lists cannot include every problematic
material, new chemicals are being created all the time, and they often do not take
into account life cycle or product context, replacing a ‘banned’ chemical with
something allowable could ultimately be equally problematic, or even worse
o For example, Bisphenol A (BPA), an ingredient commonly found in hard
plastics was removed by most manufacturers after it was discovered that
the chemical is leaching into food and drink and found in human bodies
and can have multiple hazardous results. Thought to be preferable, many
manufacturers replaced BPA with Bisphenol S (BPS). However, as Figure
4.1 shows, BPS is structurally very similar to BPA and unfortunately has
many of the same problematic properties as BPA.

Figure 4.1. BPA and BPS as an example of regrettable substitution.
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•

Basing lists on the inherent hazards of chemicals often means a lack of context
around different stages of the life cycle use of the product, manufacturing process,
end-of-life options

•

Ingredient-level chemistry doesn’t tell the whole story: “Chemistry is
complicated,”9 so assessing a product based on individual ingredients, without
accounting for interactions between those ingredients, is perhaps too simplistic.

RSLs can empower manufacturers to make sweeping changes to their products, to their
supply chains, and to make clear claims about their products. However, if the above
considerations, and others, are not taken into account at the manufacturing level and the
consumer is not educated in the broader context of product chemistry, they may not have
as positive of an impact as intended, and may even encourage poor choices. RSLs
communicate a binary situation in which the absence of a set of “bad” chemicals creates a
“safe” product, and assumes the safety of chemicals not present on that list.
List-based approaches to material health may also force manufacturers to consider
changes to products that are less than ideal from a health or from a life cycle perspective,
in order to comply with program requirements. One interviewee described having
overheard conversations where their colleagues considered replacing one chemical with
one they knew to have a worse toxicological profile, merely because it was not on the
RSL. Others described the difficulty of balancing priorities; replacing a Red Listed
chemical might result in a product with a shorter life span, thereby resulting in an
unintentional increase to life cycle impacts.
In the interviews, the products a manufacturer made were often tied to a company’s
perspective on RSL approaches. Some manufacturers were much more tied to the
ingredients that they use, while eithers can be more nimble based on consumer demand,
making across-the-board ingredient replacements harder or easier. Some manufacturers
also had few enough products that they could conduct risk assessments for all of their
products, whereas for others, the thought of using a program like Cradle to Cradle for all
of their products was laughable due to volume and cost12. Some manufacturers also found
issue in the practice of tying a Red List to a green building standard compliance as
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Declare does, feeling that it could encourage manufacturers to lie, or report their
ingredients differently, in order to be specified —changing your paperwork is often easier
than changing your product2,3,4. However, is not limited to RSLs and Declare, and falls
more broadly under the issue of self-disclosure and accuracy.
4.6.4.2

Hazard Ratings

As discussed, HPDs are primarily designed to be a communication and transparency
platform, not necessarily to serve at the architect or consumer level to directly select
products. What is more, because the HPD allows for significant variation in thresholds
and percentages of reporting, “you can’t compare two HPDs now”7. HPDs are
nonetheless being requested by architects as a pathway to LEED credits, therefore
discussion of their merit as an architectural specification tool is relevant, and important to
the manufacturers that are engaging with them.
Out of the three programs studied, the HPD is currently the only one that displays hazard
ratings for each ingredient disclosed, using the GreenScreen List Translator. Even
proponents of an ingredient-level hazard based approach to material health expressed
wariness about interpretation of the HPD. Many felt consumers might select, or avoid,
products for what manufacturers would consider to be the wrong reason—an issue
discussed earlier in the Education theme. Hazard ratings are more difficult to explain or
interpret than RSLs. A few interviewees stressed resistance within their company’s legal
departments to the presentation of hazard ratings and the HPD hazard summary. “The
summary warning is not something our legal team will ever be excited about.”2
Certain ingredients are consistently cited as examples of problems with the pure hazardbased approach to material health. Using the GreenScreen methodology, ingredients like
Titanium Dioxide, Silica, and Carbon Black, are known carcinogens in respirable form.
However, the very same ingredients, when bound to other ingredients in a material or
product may no longer be problematic. Because the GreenScreen List Translator tool
looks at ingredient-level hazard, regardless of the product-level context (i.e. physical
form, or material or product-level chemistry), these ingredients will be represented on the
HPD as a potential carcinogen whether or not there is a risk of inhalation for the end user.
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For example, silica inhaled in powder form is a carcinogen, but silica once it becomes a
glass windowpane is unlikely to be a health hazard. One interviewee described this issue
by saying, “Fundamentally…the disconnect is having to appear to be labeling your
product as hazardous when the product is not hazardous…”2 Without any context almost
anything has the potential for harm. “Water will kill you. Water’s toxic if you breathe it
in your lungs too much”1.
There is space for manufacturers to add notes and communicate some of this context to
the reader on the HPD. However, interviewees did not trust that consumers would take
the time or possess the knowledge required to adequately interpret the HPD, even with
the notes. Interviewees felt the distinction between ingredient hazard and risk is not well
understood by consumers, and many considered this distinction crucial to future
education and to progress in this field.
4.6.4.3 Risk and Exposure
Participants generally agreed that product-level risk and exposure assessments often
provide a more accurate evaluation of material health than the list-based hazard approach.
“Some of the impacts are more complicated than what Red List can really tackle. There
needs to be a human behind those decisions with common sense.”6 However, assessment
can be expensive, time-consuming and more difficult to scale for some companies with
large numbers of products, complex products, or large, complex supply chains.
Participants generally agreed that judgment can not be definitively passed on the relative
safety of a product without taking into consideration the relative risk of exposure of
individual ingredients, and the chemical reactions between different products. However,
some interviewees also felt that risk assessment and toxicology are still imperfect
solutions to the issues presented by ingredient and hazard disclosure and should not be
regarded as a panacea.
Cradle to Cradle is the only program studied in this research that incorporates full
product assessment and risk and exposure. Most participants felt this was the greatest
strength of the Cradle to Cradle program. Not only is the information gathered and
verified by a third party, but that third party also has the knowledge and methodology to
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assess not a) product content and b) relative risk and exposure routes. The chemical
supplier interviewed also described their preference for internal methodologies that look
at risk and exposure and rate chemicals accordingly. The nature of this approach, and of
Cradle to Cradle’s rating system, allows consumers to compare or rank products more
quantitatively than other approaches. However, the lack of standard and assessment
transparency makes it difficult for the public to understand or question why a particular
product would receive its score.
4.6.5

Lack of Standardization is Stymying Progress

A lack of standardization in the industry was cited as particularly problematic for
gathering, interpreting and reporting information on product content and material health.
As discussed in Chapter 2, the material health harmonization efforts are working to
improve alignment and cross-pollination between different programs and create a
baseline of data that feeds all of the systems. However, interviewees in this research
pointed repeatedly pointed to a lack of standardization at all points along the continuum
of harmonization, from inventory, to screening, to assessment, to optimization. Though
explicitly mentioned in fewer interviews than issues of education or hazard vs. risk,
standardization was central to many of the other issues.
4.6.5.1 Standardizing Content Inventory
One issue in particular is a lack of alignment around reporting levels and thresholds. A
list of contents for a piece of carpet tile can be two ingredients, or it can be close to 300,
depending on the granularity of data gathering and reporting (J. Connelly,
Correspondence, 2016). Figure 4.1 illustrates the impact that disclosure thresholds can
make on reported content. Like sieves, increasingly granular thresholds ‘catch’ more
ingredients present at lower levels, resulting in a longer list of ingredients.
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Figure 4.1. Product ingredients detectable at increasingly granular thresholds of
disclosure from left to right.

The material health programs studied in the current research have specified thresholds of
disclosure requirements, though the HPD allows for disclosure at different levels. Less
granular disclosure thresholds (i.e. 10,000 ppm) may allow manufacturers to leave off
some of the most problematic materials, as these are often present at lower percentages of
the final product content (i.e. ingredients in coatings, epoxies, or recycled content
impurities). Declare requires disclosure of >99% of ingredients in the final product at
100ppm, where HPD allows manufacturers the option of disclosing at different
thresholds, as well as withholding varying amounts of information, and completing an
HPD without necessarily having a complete understanding of the content inventory (in
this case the must specify that all ingredients have not been characterized and screened).
There is not necessarily agreement in the industry of how deeply we should be
identifying chemical presence in products, and at what level the utility of further
characterization ceases to be useful. Is disclosing recycled materials such as crushed PVC
still useful at 10,000ppm, or will it just miss most of the problematic residuals that might
be present in a product?11
Accurate disclosure is also highly dependent upon consistent and correctly interpreted
communication of requirements within the supply chain. Even if a manufacturer requests
a certain level of information, they are often dependent on their suppliers to interpret and
provide the level of information they need. Independent testing of products can be done
to verify the information provided, but this is costly and cannot be used in all cases11,12.
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Accurate and honest reporting by manufacturers was also considered an issue, where
some interviewees felt some manufacturers, were “far too comfortable” with inaccuracies
that would benefit the appearance of their product.
Interviewees also described facing what is known as the “innovator’s dilemma”.
Companies founded on principles of transparency were interested in disclosing their
ingredients, but felt that they couldn’t do so without a level playing field. When an
ingredients label with complete disclosure of ingredients is held up next to a label with an
almost identical product that discloses slightly less information, the fully-disclosed
product may a) reveal more proprietary information thus putting them at risk and b) look
‘worse’ in terms of material health.
CAS#s are also an imperfect system of identifying chemicals, and interviewees expressed
frustration at times with having to provide “bogus” CAS#s for programs like Declare
when an appropriate one did not exist. For example, one can obtain a CAS# for a polymer,
but the true final composition of that polymer can vary widely depending on the
production of that polymer. Polymers themselves can be generally innocuous, however if
manufactured in less than ideal circumstances, there may be high levels of residual
monomers left in the polymer—and these monomers are often of more concern. So the
identification of the residual monomers may be more important than just providing a
CAS#.
4.6.5.2 Standardizing Screening
The three main programs studied in this research all involve a baseline level of screening
ingredients against Restricted Substances Lists to determine presence or absence of
certain chemicals—what each program considers the “worst-in-class” classes of materials
or chemicals. Screening against lists provides manufacturers with a simple measure of
how their product performances in terms of avoidance of certain chemicals and materials
in products. However, as determined by the Lowell Center for Sustainable Production
(2008), what is on these lists and the reasons for their presence on a list can vary widely
from program to program. Restricted Substances Lists used for screening can vary hugely
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across programs, across industries, or even just from one manufacturer to another (Lowell
Center for Sustainable Production, 2008).
Differences between lists can mean that the same product ingredient is flagged as
problematic in one program, but may present no issues in another7. Many manufacturers
and architects also have their own internal RSLs (Fransson, Brunklaus, & Molander,
2013; Kogg & Thidell, 2010; Lowell Center for Sustainable Production, 2008). “The
process may be the same but if you’re not even starting with the same data points, you’re
gonna get skewed results,”7 therefore interpretation of screening may feel arbitrary at
times to some manufacturers.
4.6.5.3

Standardizing Chemical Assessments and Optimization Efforts

Assessment is the next step after screening along the material health continuum described
by Heine et al. (2013). Declare and HPD use inventory and screening, and Declare uses a
banned list of chemicals. However, neither program goes beyond this to fully assess the
hazards present in the product beyond a screening process. Interpretation of results is
ultimately left to the customer in those programs, aside from the distinctions made
between Declared, LBC Compliant, and Red List Free made by Declare (see Chapter 2).
Most participants felt that risk analysis was important to understand the context of the
product composition, and the life cycle. Even those that approved of the simplicity of the
hazard approach to determining material health felt that full assessment of chemicals
within a product using the GreenScreen or C2C methodologies provided a more in-depth
understanding of the ingredients. Risk and exposure assessments add context and better
prioritization of any issues. For example, if a product contains a restricted chemical such
as phenol formaldehyde, which potentially has dangerous emissions, but it meets
stringent air quality standards, “then there’s no risk, so what are we talking about?”12
Still, some warned that risk analysis was still itself in its infancy and not a replacement
for understanding the inherent hazards of product content, nor a panacea for the issues
being faced in the industry approach to better products. One interviewee remarked, “risk
assessment is so imperfect that I’m not going to default to saying that’s what the issue
is.”2
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Beyond these issues, a position expressed by some interviewees was the need for an
industry-wide initiative where”everyone has to get together to agree on what they will
provide—on some level of information,” otherwise “we’re just going to splinter and
splinter and splinter until we get everyone back at the table.”7 This would require the key
players in the industry to come together and agree on a basic threshold. There also
remains the question of whether nonprofit-administered standards have the potential to
agree on levels and types of information, nor whether selective participation by different
manufacturers and different firms in different programs is useful overall. As one
participant pointed out:
Holistically- and at a high level I can’t see people agreeing on what they
want out of these tools. If only certain manufacturers are participating and
design firms that like it for this reason, how does that help everybody?
That’s always the challenge, and that’s why everyone continues to spin off
and make their own programs.7
4.6.6

Prioritization

Participants felt it was important to prioritize what materials we tackle first. Dealing with
the most problematic issues, and then working down a list allows for the greatest initial
impact. “Let’s get a stake in the ground, a working piece, and continue to add on and
strategically look at it…What is the most impact? What are the things I’m most
concerned about in the industry and products? What are we concerned about in firms?
And working it down from the top down.” Where product coatings are concerned, for
example, what is appropriate for space travel may not be the same as what is appropriate
for painting an elementary school.
Proactive vs. reactive actions were also emphasized by a few of the participants. One
example given by an interviewee dealt with the previously discussed issue of regrettable
substitutions. The California Safer Consumer Products Regulation requires manufacturers
to conduct alternatives assessments for certain harmful chemical ingredients widely used
in products. While a laudable attempt to control for problematic chemical substitutions,
the example was held up as a cautionary example of the prohibitive time and money
required for this type of assessment. Perhaps instead of requiring alternatives assessments,
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more proactive solutions might move the needle further, faster. By that same philosophy,
working to locate and expunge all traces of problematic materials in a chair may not be
the best use of one’s time. None of the interviewees specifically referenced the creation
of “good lists” or “green lists” referred to in the research done by the Lowell Center for
Sustainable Production (2008). However, interviewee feedback was in line with the
findings that some manufacturers are looking to create “positive criteria” for products
rather than focusing on avoidance. A number of interviewees referred to the idea of
actively searching for better materials rather than only focusing on what to avoid or
eliminate from products. “An hour spent tracking down potential [Chromium] VI on a
caster is an hour less time finding an solution. I know we need disclosure or transparency
but I want to balance it with proactive changes.”10

4.7

Pilot Survey

Once interviews were complete, a survey questionnaire was assembled based on the
researcher’s knowledge of the field and informed by the interview responses. A pilot
survey was first sent to 8 of the interview participants who had expressed a particular
interest in the study. This pilot survey was intended to gather initial feedback on the
survey in order to gather feedback and determine if there were any issues in the questions
prior to releasing the full survey.
There were six responses to the pilot survey. Participants in the pilot survey were
prompted to either provide feedback at the end of the survey, or to send feedback
separately in an email. Two of the six respondents emailed the researcher separately to
provide feedback and elaborate on their responses in the survey.
A number of issues around question clarity were pointed out. In addition, participants
pointed out a few questions where the response mechanism (i.e. answer selection method)
in the survey was not in line with the question or seemed to be problematic. These
questions were revised accordingly prior to distribution of the larger survey. Additionally,
the researcher identified a few additional areas of interest, such company position in the
supply chain, and supply chain size, and added questions about these to the survey.
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4.8

Full Survey Analysis

The full survey was sent to 76 manufacturers in the U.S. building product industry.
Manufacturers were identified from a similar population as the interviews. Participants
were identified through their association with the various material health evaluation
programs focused on in this research.
Complete responses were obtained from 37 manufacturers, though five were ultimately
excluded due to having been completed by manufacturers based in other countries. This
research was focused on U.S. manufacturers, due to differences in regulations. The 32
analyzed responses represent a response rate of 42.1%. While the response rate was high,
the researcher acknowledges that the number of responses is too small for extrapolation
from the data gathered. However, the aim of this research was not to predict the
perspectives of the entire industry, but to understand the perspectives of leading
manufacturers.
Some of the questions in the survey were designed to determine whether a
manufacturer’s position in the supply chain and their product sector would their
perspective on the issues of transparency and disclosure. However, manufacturers rarely
fell into neat categories along the supply chain or within an industry. More often, the
manufacturer supplied different types of products to different consumers in different
sectors. Therefore it was difficult to neatly group the manufacturers and analyze the data
along these lines.
Surveys consisted of 29 questions. A further two questions were optional and open-ended.
Responses to the survey are described below (the survey questionnaire can be found in
Appendix D). The survey was divided into 6 sections:
•

Company Background

•

Awareness & Use of Material Health Declaration/Evaluation Programs

•

Company Approach to Material Health

•

Supply Chain Interaction

•

Company Perspective on Material Health Information

•

Transparency + Regulation

71
As Likert-type responses were employed often in the survey, descriptive statistics are
used where appropriate—such as describing the mode and frequencies (Journal of
Extension, 2012).
The following section first describes the sample obtained, and then discusses relevant
results from each section of the survey.

4.9

Company Background

The first eight questions gathered background information on both the company and also
on the participant’s role within the company. When asked first about the company’s role
within the supply chain, the majority of respondents reported that they sold finished
goods, either to other businesses or to consumers (Figure 4.2). Respondents that
described their companies as producing chemicals, chemical mixtures or materials were
the smallest group (19%). Participants had the option to select more than one answer, as
many manufacturers fall into multiple categories, due to either the range of one their
products, or because some companies have multiple businesses, some of which are more
consumer-facing, and some of which act more as suppliers to other businesses. The
purpose was to determine where some of the companies lie in the supply chain, and
whether that would influence their perspective on transparency and their perceived
barriers to transparency in the industry. Most of the manufacturers fell under multiple
categories, which made connections between supply chain position and perspectives on
material health transparency more difficult to link.
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Figure 4.2 Company Role in Supply Chain.

Sample companies also represented a range of product types. The largest category of
respondent product type was furniture. Beyond that, wood products, flooring, and
insulation were equally represented as the second largest product types. Once again,
many of the manufacturers produced products that fell under multiple categories,
meaning they may encounter sector-specific issues (formaldehyde in wood, proprietary
textile ingredients, recycled content) in multiple sectors.
When asked about the size of the company, 31% of the participant’s companies fell in the
mid-range of 1,000-5,000 employees. Two companies had more than 10,000 employees.
The two largest companies in terms of employees were manufacturers of bathroom
fixtures and furniture products.
Survey respondents had a number of different roles at their company. The greatest
number of respondents worked on their company’s sustainability team. Others were
involved in sales, marketing, research and development, and manufacturing, engineering
and management. All participants described some degree of interaction with material
health evaluation, disclosure or chemicals-related issues at their company.
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Of the seven companies that reported having over 5,000 employees in their company,
three of the companies reported having less than five employees working on issues of
material health. Half of the companies surveyed (16 participants) reported having two or
fewer individuals working on these issues of material health and disclosure. Of the nine
companies who reported annual revenues of over 1 billion USD, 3 participants had more
than 11 employees working on these, and three of these companies had three or fewer
employees working on these issues. This indicated that the size and revenue of a
company did not necessarily determine the amount of resources being devoted to issues
of material health and disclosure. 34% of respondent’s companies had domestic supply
chains, and 66% reported having global supply chains.
4.9.1

Awareness and Use of Material Health Declaration/Evaluation Programs

Out of the programs studied in this research, most participants had engaged with Declare
(25), then with the HPD (21), and the fewest with Cradle to Cradle. Every participant,
however, had at least heard of Cradle to Cradle, while 1 participant reported being
unaware of Declare, and 3 were unaware of the HPD standard.
Cradle to Cradle was responsible for the fewest number of overall products certifications,
while HPD was responsible for the most. This makes sense as HPDs are a free and open
standard, and Cradle to Cradle is the most expensive and requires third party engagement.
The largest number of respondents also reported HPDs as being the most requested
standard by consumers, while Cradle to Cradle was the least requested. Participants
reported the greatest involvement overall in the HPD out of the three programs.
4.9.2

Company Approach to Material Health

Participants were asked to rate a number of drivers in terms of their influence on their
company’s engagement with the voluntary material health programs identified in the
study. Overall, out of the factors identified as having “a lot” of influence on their
engagement, “Consumer Demand” was identified the greatest number of times, followed
closely by “Building Certification Programs” (17) and then by “Company Mission” and
Values (16). Overall, participants indicated that “International Regulation” had the least
influence on their participation in the programs. However, it is possible that international
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regulation may have a large influence on some companies’ material health policies and
the direction of the green building movement overall without employees being directly
aware of this influence. When asked about the impacts of engaging with these programs,
an increased knowledge of their product content was selected the most often as a result.
Increased confidence by consumers in the company was also identified as being a relative
impact of program engagement.

4.9.3

Supply Chain Interaction

Participants were asked about the number of their first tier suppliers, and the number of
overall suppliers to learn more about supply chain size and complexity for manufacturers.
The number of first tier suppliers for each company ranged from 2 (these participants
reported that their company produced wood products and furniture) to 2,500. It stands to
reason that the types of issues faced by manufacturers with such different supply chain
structures might be quite different. Five respondents reported having thousands, even
hundreds of thousands of suppliers in their total supply chain. Gathering ingredient
information from a supply chain of thousands is a big undertaking. One respondent
answered that their company had too many suppliers to estimate; their company produces
a large range from products including plumbing lighting, electrical, wood products,
furniture and bathroom fixtures.
When asked what percentage of their entire supply chain they had engaged to collect
ingredient and material health information, respondents . The 15 participants who
responded that they had engaged 51-100% of their total supply chain, reported having
between 2 and 50 first tier suppliers—very low numbers compared to the thousands
reported by some of the participants. Manufacturers with much larger supply chains had
engaged less of their supply chain.
4.9.4

Company Perspective on Material Health Information

Participants were asked to rate a number of factors from 1-5 (5 being the most important)
in terms of how important they were as a barrier to further public disclosure to
ingredients. The proprietary secrets of the manufacturer’s supply chain were identified as
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the largest barrier (13), and supply chain resistance to disclosure followed closely (11).
These were trailed by lack of demand for transparency from customers (8), and the
manufacturer’s own trade secrets/proprietary information.
Most of the respondents reported that their company’s Restricted Substances List was
created internally, rather than being based only on a regulatory standard or from one
material health standard. This is interesting, as it is occurring at the same time that
programs are attempting to harmonize and align their lists. If every manufacturer is
creating their own RSL, it would be interesting to study whether these efforts serve the
industry as a whole, or whether they creates the potential for further fragmentation in the
industry.
When asked about the utility of different aspects of material health to consumers, from
ingredient lists to risk and exposure, product-level risk assessment and the presence or
absence of Chemicals of Concern were identified as being the most useful aspect of
material health to communicate to consumers. Ingredients, CAS#s and hazard ratings
were considered less useful. Product-level risk assessment is only carried out in C2C
currently.
4.9.5

Transparency and Regulation

61% of respondents felt that market-driven solutions were more likely than federal
regulation to lead to a healthier materials market. This argues for improving the utility of
these programs.
When asked to define the term transparency as it pertains to the building product industry,
participant definitions varied very widely. Leaving the question open-ended allowed for
gathering participant’s definitions unbiased. However, providing a few definitions might
have helped to better categorize participant’s responses. It is clear, however, that
interpretations of the term transparency are very different from manufacturer to
manufacturer. Even looking at subgroups of data by product type or place in the supply
chain, the participants provide very different definitions. Some respondents expressed
mistrust of the intentions of disclosure; that releasing information that might be used for a
“hidden agenda”. Another stressed the difficulty of true accuracy in transparency, calling
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transparency “a unicorn” in supply chains with multiple in-feeds, inherent uncertainty
and multiple tiers of suppliers.
The full list of participant-given definitions to transparency and material health are given
in Appendix E. At one end, respondents defined transparency as “Safety Data Sheets”
(OSHA-required information), while at the other end some participants make references
to hazard, risk, and the complexity of defining the term at all. Some definitions refer to
the whole product life cycle, while others talk just about harm to the end user. This
indicates that there are mixed signals in the marketplace, and mixed interpretations of
what is expected.
When asked to define ‘material health’ as it pertains to the building material industry,
similar responses were given. One respondent wrote “The fact that we’re still asking for
definitions says it all,” likely referring to the difficulty of attaining something that is asof-yet undefined. Some respondents raised the issue of risk versus hazard as a means of
assessing product safety. Different definitions focused on different areas of the life cycle.
Some definitions were focused solely on human health impacts while others raised the
issue of environmental impacts.

4.10 Chapter Summary
This chapter reviewed the responses from both the interview and survey portions of the
research. Deviations from the original proposal were discussed. Interviews were analyzed
using six overarching themes and their subcategories, and perceived barriers to further
engagement with the voluntary material health programs were introduced. For the survey,
questions were analyzed using descriptive statistics, using graphics to aid in presentation
of the material when necessary. These results and their application in answering the
research questions will be discussed in the following chapter.
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CHAPTER 5. CONCLUSIONS, DISCUSSION AND RECOMMENDATIONS

5.1

Introduction

This chapter synthesizes interview and survey results described in the previous chapter,
along with supporting evidence from the review of the literature to draw a number of
conclusions about the current research. These conclusions are then discussed within the
context of some larger industry issues and compared to existing literature. The limitations
of the study are presented, followed by potential applications of these conclusions and
ideas for future research.

5.2

Answering the Research Questions

The past few years have been a time of rapid change in the building products industry as
green building begins to enter mainstream construction, and what we consider ‘green’
expands beyond energy efficiency. Consumer demand for greater information around the
content and health impacts of products has driven the creation of a number of material
health evaluation programs. These programs demand standards of material health and
disclosure of content information in excess of what is required by federal chemical
regulation in the US. In a slow-moving, commodity-based market that has held much
information proprietary, voluntary engagement with issues of material health requires
significant rewiring of how manufacturers source and track what is in their products, how
they disclose what is in their products and what that means for customers, and how they
communicate the value of product transparency, disclosure and safety.
The intent of this study was to invite building product manufacturers to talk openly about
their perspectives on this movement towards transparency and disclosure around material
health. Is the push for more information beneficial or problematic? What are the issues
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manufacturers encounter in trying to participate? Where do they see material health
efforts headed?
Barriers to gathering and communicating information about products may point to
potential areas for improvement in material health programs and avenues for accelerating
participation. The hope is that accelerating participation to reach a critical mass will
contribute to a more transparent and safer building materials market, and a more
informed public.
The three questions guided this research:
1. What are the barriers, both real and perceived for U.S. building product
manufacturing companies to engaging with voluntary material health programs?
2. What is the manufacturer evaluation of the three main material health programs?
What are the barriers to adoptions? What are the benefits to participation?
3. How do manufacturers define transparency? To what extent do manufacturers feel
transparency is a prerequisite to achieving a building product industry that is safe
for humans and the environment?
While synthesizing the research findings, these questions were reorganized and
simplified to better separate barriers from solutions and improve the clarity of the
conclusions. The three questions below are therefore answered in the following sections:
1. What do manufacturers perceive as the main barriers to program
engagement, and thus to ingredient and hazard disclosure?
2. What solutions will help overcome those barriers and achieve a healthier
product marketplace?
3. Are transparency and disclosure crucial to those solutions?

5.3

Research Question 1: Barriers to Engagement

Interviews and surveys revealed many perceived barriers to further adoption of voluntary
material health programs faced by US building product manufacturers. These barriers
have been grouped into five overall categories:
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1. Lack of resources to devote to material health efforts
2. Not enough standardization of ingredient definition or thresholds, nor how to
interpret and communicate data to consumers
3. Insufficient consumer education
4. Proprietary supply chains make gathering information difficult
5. Single-attribute programs may incentivize the wrong choices
5.3.1

Lack of Resources

Many of the companies engaging with issues of material health do not have sufficient
resources to scale efforts across product lines. Tracking material health information for
even one product, let alone thousands of products, can be difficult. Most manufacturers in
the study reported data management issues, due to a) supply chain size, location of
suppliers (often supply chains were international) and dynamic nature of supply chains,
and b) product complexity and configurability of products (especially surrounding colors
and textiles).
Generally, participants reported small staff size responsible for engaging with material
health programs. Some of the participants in this study represented their company’s entire
sustainability team. Often, those participants are engaged with sustainability at both the
company level and product level. Just at the product level, the same products are
generally pursuing a significant number of certifications surrounding many different
attributes. Manufacturers reported difficulty balancing these efforts in terms of time, cost
and effort. Without significant demand and return on investment, it can be difficult to
prioritize material health when so many other product attributes exist and are important
for product aesthetics, performance and price.
5.3.2

Lack of Data Collection, Interpretation + Communication Standardization

Lack of alignment between the three material health programs studied is another barrier
to engagement previously identified by Heine et al. (2012) in the program harmonization
effort. The lack of consistent definition of how to define and gather content inventory is
perhaps the most problematic portion of this. Determining what is considered to be an
ingredient is sometimes inconsistent. It can be difficult for manufacturers to know
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whether a product should be described as the sum of its input ingredients, or whether the
final product is fundamentally different on a chemical level without expensive product
testing. Lack of definition and alignment around this issue can make the collection of
ingredient and hazard information more difficult and confusing than it need be.
Reporting ingredient information at different thresholds for different programs may also
mean manufacturers have to make multiple asks of their suppliers. Overall, this also
means that the manufacturers cannot be as confident that reporting of ingredients is
consistent across products and different companies.
It is also clear that the collection of data from suppliers is fairly haphazard at this point in
time. While some manufacturers have developed systems for data collection, most are
still Also, many participants reported a need to be flexible in their data collection efforts
in order to engage suppliers that might otherwise resist disclosure. Receiving information
“in 10 different ways from 10 different suppliers”7 can make interpretation of supplier
information more cumbersome and time-consuming.
Each of the three programs studied in this research presents different types of material
heath information in a different format to consumers. Program developers should
carefully consider what information should be consumer-facing, and which should be
reserved for communication within supply chains so as not to provide consumers with
information they cannot adequately interpret.

5.3.3

Consumer Education

Lack of consumer education was another significant barrier identified in this research.
The production and disclosure of ingredient and hazard information is very important for
closing the existing data gap. However, without appropriate levels of information and
associated education for consumers, the release of data may not be used as intended. Lack
of education for consumers can mean a) better products are ultimately not selected over
worse ones, or potentially good products are actually avoided because consumers are
scared off by complicated hazard information, and b) lack of demand for program
engagement by manufacturers. Education should be centered on the distinction between
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hazard and risk, and the roles of the different programs in trying to address material
health. Consumer demand is a large driver of manufacturer engagement with these
programs and product changes overall. Their education and participation in this process is
crucial to reaching a critical mass of adoption.
5.3.4 Proprietary Supply Chains
In a global, mainly commodity-based market, complex supply chains make it difficult to
gather specific information and have confidence in the accuracy of that information.
Proprietary and trade secret claims in supply chains were a major barrier to program
participation and disclosure identified by participants in this research. While HPDs and
Declare labels are most often self-reported, without supplier cooperation manufacturers
must either conduct expensive product testing, engage a third party verifier, or make an
educated guess about content which some manufacturers are not comfortable with. Often,
third party engagement requires a non-disclosure agreement to be signed between the
third party and the supplier; therefore the information often cannot be given to the final
manufacturer, nor disclosed to the public. This parallels findings by Scruggs and
Ortolano (2011) that proprietary claims and information lost in complex supply chains
were one of the main challenges facing European consumers in trying to comply with
REACH regulations. Figure 5.1 illustrates one example of a complex supply chain.

Figure 5.1. Supply chain complexity for a fashion retailer (Kogg & Thidell, 2010).

82
The manufacturing companies represented by participants in this research are considered
leaders in the transparency and material health movement, Overall, consumer-facing
manufacturers encounter greater demand for these material health programs, and are
likely to be bigger proponents of ingredient and hazard-based disclosure for products.
However, those manufacturers are still tied to their supply chain and suppliers often
perceive greater risk in participating with these programs. The value of what a chemical
supplier produces lies within the formulation of their product, whereas the overall
assembly and design of a chair, for example, is what makes it special. Suppliers capable
of actually creating chemicals higher up in the supply chain are less likely to want to
disclose granular information.
5.3.5 Single-Attribute Tradeoffs
Material health is a crucial component of product sustainability, and therefore of the
sustainability of the built environment. However, manufacturers must consider the
impacts of product changes and reformulation outside of just material health. Each
change to a product can potentially have a cascade of effects around price, life cycle
impacts, and durability. Some participants pointed out the danger of too narrow a focus
around health and toxicity. As one of the interviewees from this research pointed out:
The health thing is so hot right now and it is so immediate and people are
so scared about it. It’s so new and so fresh and so scary and we’re fixated
by it, and I’m not gonna say it’s wrong and we should be getting better
chemicals. But we have to be careful about, about if we focus on that to
the exclusion of everything else what are we going to be sacrificing?2
Cradle to Cradle was the only multi-attribute program studied in this current research.
Even Cradle to Cradle, however, does not incorporate life cycle information.
Manufacturers have a huge number of factors to consider in their supply chain. Getting
rid of an ingredient may mean price differences; bio-based adhesives may not perform as
well as synthetic; replacing an ingredient in a coating may require re-application sooner.
Sometimes there is no significant tradeoff, or a product performs just as well without an
offensive ingredient, but it is important to consider these issues alongside health and
toxicity to make sure that programs are encouraging positive change.
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5.4

Research Question 2: Potential Solutions

RQ 2: What solutions will help overcome those barriers and achieve a healthier
product marketplace?
The five categories of solutions parallel the barriers outlined in the previous research
question:
1. Standardization of Data Collection
2. Interpretation + Communication
3. Education
4. Supplier Engagement
5. Multi-Attribute Thinking
5.4.1

Standardization of Data Collection

Further cross-pollination between the three programs would thus be beneficial for
engagement. Increased harmonization of baseline data needs for each program would
mean that the manufacturers and programs would be speaking with a common voice to
upstream suppliers, potentially increasing the quality and quantity of data and decreasing
the time and cost involved in gathering information. Standardization of data collection
requirements mean that programs can continue to compete, but data feeds multiple
programs, requests are more consistent, streamlined and accurate.
Many of the other barriers identified in this research appear to be connected to this issue
of standardization. Further adoption of transparency and material health thus also feel
predicated on the establishment of greater standardization and harmonization. Without
further standardization, efforts in other areas will be diluted by conflicting methods of
data collection, assessment interpretation, needs for education.
Further harmonization of programs and standardization of expectations and interpretation
will allow the most efficient use of time and resources and expedite uptake of these
principles and progress in the market. Lack of standardization leads to market confusion,
reluctance to disclose before competitors, and difficulty in interpreting information
presented by these programs. The differences in philosophy underlying the various
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programs—what are the most important aspects of material health or disclosure to the
program developer—are largely what create these divisions and can be difficult to
overcome Kokai (2014). The program developers recognize these differences in their
paper on harmonization opportunities, pointing out that while standardization is
important, this does not mean that all of the programs necessarily need to merge at this
point (Heine et al., 2012). The differences in approach by different programs may serve
the market by allowing different points for entry by different manufacturers, and allowing
for market differentiation. However, if all of the programs could agree on the
standardized collection of data (which is partly the intention of the HPD), perhaps the
programs could continue to compete based on their interpretation of that content
inventory.
Another large barrier is a lack of standardization in how material health information is
defined, gathered, communicated and interpreted. The more that the industry can speak in
a common voice, the more consistent the demand and response for information will be.
Currently, manufacturers are requesting information from their many suppliers, and
receiving the requested information many different ways. Their suppliers are being asked
for lots of different information to feed different programs using different formats.
Flexibility is important to allow suppliers to provide information in a manner that suits
them, just as having multiple programs is important for allowing final manufacturers to
pursue an avenue that fits their model. However, if programs align enough so that
manufacturers request the same common baseline of information from each supplier, the
work will become easier for all parties involved. Streamlining the process of gathering
information through standardization of requirements, downstream aggregation of content
inventory information, and possibly tying material health information to other
measurements such as life cycle analysis data may help to decrease redundancy and make
material health part of the process rather than an additional cost.
5.4.2

Interpretation + Communication

Wherever possible, material health programs need to communicate to consumers with a
common voice to increase recognition of these issues and decrease confusion in the

85
marketplace. Consumer-facing programs also need to make content presentation and
product comparison intuitive so that it is easy to select the most appropriate product.
Also, clear communication from each program about the purpose of each program will
also help to improve the use of programs. All three programs studied in this research play
a different role. The HPD standard as it exists, should not be used by architects or
consumers to specify products, as the standard a) does not pass judgment on the relative
health or safety of a product and b) is not easily interpretable by architects who often lack
the knowledge and time to decipher the document. The HPD Standard can, however,
serve a crucial role in the collection and communication of standard information used to
feed other programs that are designed for interpretation.
Declare is useful as a decision-making tool for architects and allows for clear
communication for manufacturers about product content, but there are significant
limitations around using a red list screening approach for products. HPDs are free to
create and Declare is low in cost, allowing more manufacturers to engage.
Cradle to Cradle is the most easily interpreted by consumers due to its rating system, is
the only program that deeply approaches risk and exposure, and is multi-attribute. It also
provides an avenue for manufacturers to engage with material health that are not willing
or able to disclose product ingredient and hazard information. However, its lack of
transparency in both the standard and the program output, along with the high cost, can
be unappealing to many manufacturers, and a deterrent to participation.
The differences in philosophy underlying the various programs are largely what create
divisions in interpretation and communication, and can be difficult to overcome (Kokai
(2014). These different approaches, however, may serve the market by allowing different
points for entry by different manufacturers, and allowing for market differentiation. If all
of the programs could agree on the standardized collection of data (which is partly the
intention of the HPD), perhaps the programs could continue to compete based on their
interpretation of that content inventory.
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5.4.3

Consumer Education

Consumers were consistently identified as the greatest driver of change overall. This
argues for focusing on education a) within the building industry to change perceptions
and foster an industry of building professionals that understand and value the importance
of material health alongside more traditional building specifications; and b) for
consumers and the general public to grow demand and increase pressure for better
products and green chemistry. These principles have to be carried out throughout the
entire supply chain down to the contractors, subcontractors and consumers in order to
truly be impactful.
Greater education for consumers around the purpose of each program, and how to
interpret the information provided by each program would make the final manufacturers
and their suppliers more confident in the benefits of participation and might ease fears
about misinterpretation of complicated hazard information in programs like HPD. The
movement is very much in its infancy, and beyond the leaders in the industry, this
education also needs to extend to other manufacturers in the industry.
However, even if some consumers are properly educated about material health, they
should not necessarily need to understand how to interpret a list of hazard ratings in an
HPD. As much as consumer-facing programs can make their output information userfriendly for decision-making, the more it will incentivize better decisions. Fransson (2013)
also discussed the need for the provision of appropriate levels of information to the
appropriate parties.
5.4.4

Supplier Engagement and Scalability

In a global, mainly commodity-based market, complex supply chains make it difficult to
gather specific information and have confidence in the accuracy of that information. Even
when manufacturers were able to gather data, some expressed reluctance to publish
claims that were hard to confirm without testing every product. Supplier engagement may
help here. If final manufacturers can establish basic material health reporting or standard
requirements for their suppliers aligned with multiple programs, they may be able to
gather better, more accurate data.
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More education for suppliers around the purpose and application of the information
requested would perhaps also increase their comfort level with disclosure. Ultimately, it
will be important to find a common set of requirements that allow suppliers to protect
what is truly proprietary information, while giving final manufacturers, and therefore
consumers, the information needed to make a determination about a product’s relative
safety.
Scalability was highlighted as a crucial component of any solution. Another potential
solution is to move to a model that collects data beginning upstream with suppliers, and
aggregates that information down the supply chain. This would reduce the redundancy of
information requests, potentially also reducing the time it takes to make progress and the
cost of engagement with programs. Some programs like Material IQ and Proscale have
begun to investigate the possibility of this model.
Alignment of how programs interpret risk and exposure from products chemicals will
also serve to increase confidence in the output of programs. While differences in the
programs do serve the market by offering different levels and methods of engagement,
inconsistencies in all of these stages of material health assessment should ultimately
decrease in order to speak with a common voice to a larger audience.
Ultimately, this raises further questions. How can suppliers be further engaged? How can
these programs be better adapted to engage manufacturers or incentivize them to
participate? How do we incentivize supplier engagement? Is it possible with the current
systems? How do we create the consistent demand they might need to act?
5.4.5

Multi-Attribute Thinking

Material health is not a siloed issue. Changes made to product chemistry affect other
attributes, and may cause tradeoffs in other environmental properties. Multi-attribute
thinking, and therefore, multi-attribute programs or databases that aggregate life cycle
and material health information, will allow for better decision-making based on the needs
of the consumer.
Additionally, there are new programs appearing all the time. GreenCircle Certified has a
multi-attribute product standard that was mentioned in one interview and the Living
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Product Challenge is a transparency-based multi-attribute standard, administered by the
International Living Future Institute. These programs both take a more holistic approach
to material health that offers more for companies that are looking for transparency with a
more holistic approach to product sustainability. None of the manufacturers necessarily
identified any of the voluntary material health programs they had engaged with as
‘perfect’. Still, each offered them aspects that were important to their company. Some
expressed hope that a central, ideal program would arise, while some others felt that
resolution around a single program was highly unlikely.
Trying material health information to specifications and life cycle information can
potentially better integrate toxicity considerations earlier in the design process. This can
also contribute to achieving changes at scale.
5.5

Research Question 3: Transparency and Disclosure

The characterization or definition of transparency is not so simple as the original research
question posed. Participants described a significant amount of confusion in the market
around the terms disclosure, transparency, material health and sustainability; something
that had occurred even in this study. All participants ultimately defined transparency
differently, depending on a host of factors. As a whole in the industry, or even in one
sector (i.e. carpet), or within a company it would be difficult to obtain a consistent
definition of what transparency is.
Transparency was generally recognized by participants to be an important step forward in
the building products industry. Though transparency mainly refers to an honest
relationship with ones customers, content and hazard transparency is an important piece
of the movement. With disclosure and transparency comes a conversation about the status
quo, and about where the industry needs to head. Transparency and disclosure can make
manufacturers question what is in their products before they even engage with a program.
The precise definition of what material health transparency means to the industry is
evolving as the industry learns and consumers become further educated.
Transparency is the mechanism by which we begin to define other factors. By creating an
open dialogue, and a conversation of comparison, transparency can stimulate change and
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education. Alone it is not enough to cause sweeping change, however it is a crucial
component of the solution. The transparency movement is still very much in its infancy.
The difference between transparency and disclosure was an important distinction made
by participants. Disclosing content does not necessarily mean that one has been
transparent. Disclosing all of the ingredients in your product can be a list of three
ingredients, or three hundred depending on the disclosure threshold. To be transparent
one should communicate the level of disclosure and the reasons.
Transparency has been fundamental in opening up a conversation of a comparison and
breaking down old ways of thinking about proprietary information. What is really
proprietary? What ingredients are crucial to our product? Even having to consider how
one’s product might look if publicly disclosed may cause a manufacturer to begin
questioning what is in their product, and whether it really needs to be there. In some cases
a chemical may be necessary for the function of a product, in others it may not be, or a
better alternative may exist. Regardless of the answer, this is an important question that
industry, and manufacturers, should be asking themselves. As was pointed out in the
research “If it’s relatively easy, transparency can make it happen even without getting to
market.”2 Transparency is part of the foundation of a safer products market, though it is
far from a total solution for achieving better products across the industry in and of itself.

5.6

Discussion

The complexity of addressing material health in a mostly commodity-based market
cannot be overstated. Progress can be slow in a country where federal regulation of
chemicals is woefully inadequate, and in a market where the material health of products
is generally undervalued in favor of price and performance. Businesses are often global in
nature, and the structure and length of supply chains can make certainty about product
content a difficult, or impossible task.
Despite this, consumer demand, advocacy and green building certification programs are
driving the adoption of voluntary material health programs, and hopefully, pushing the
market towards taking greater care to understand the impacts of chemicals and materials
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in products before distribution in order to avoid issues of human and environmental
health.
Though significant progress has been made among early adopting manufacturers,
acceleration of material health program adoption beyond these initial leaders is required
to impact the market and catalyze real change in the industry. The purpose of this
research was to determine how early adopting manufacturers are interpreting the call for
transparency and disclosure of product content, in order to inform the future development
of these, and other programs. Are the programs being used as intended, what major
barriers exist to further progress, and what potential solutions exist to those barriers?
With disclosure and transparency comes a conversation about the status quo, and about
where the industry needs to head. Transparency and disclosure can make manufacturers
question what is in their products before they even engage with a program. The precise
definition of what material health transparency means to the industry is evolving as the
industry learns and consumers become further educated.
Transparency does not need to be public disclosure of the formulation of a product, and
assurance that it is not may assuage supplier fears. Product-level assessment and risk
exposure are important to providing a truer picture of material health—but in addition to
ingredient and hazard disclosure. With rising levels of synthetic chemicals found in
humans and animals and the environment, open conversations about what is in products
we sell, use and dispose of—and what is absent from them—is important.
Clear communication from each program, and from the manufacturers that engage with
them about their purposes will also help to decrease confusion in the marketplace. All
three programs studied in this research play a different role. The HPD standard as it
exists, should not be used by architects or consumers to specify products, as the standard
a) does not pass judgment on the relative health or safety of a product and b) is not easily
interpretable by architects who often lack the knowledge and time to decipher the
document. The HPD Standard can, however, serve a crucial role in the collection and
communication of standard information used to feed other programs that are designed for
interpretation. Declare is useful as a decision-making tool for architects and allows for
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clear communication for manufacturers about product content, but there are clear
limitations around using a red list screening approach for products. HPDs are free to
create and Declare is low in cost, allowing more manufacturers to engage. Cradle to
Cradle is the most easily interpreted by consumers due to its rating system, is the only
program that deeply approaches risk and exposure, and is multi-attribute. It also provides
an avenue for manufacturers to engage with material health that are not willing or able to
disclose product ingredient and hazard information. However, its lack of transparency in
both the standard and the program output, along with the high cost, can be unappealing to
many manufacturers, and a deterrent to participation.
Overall, consumer-facing manufacturers encounter greater demand for these material
health programs, and are bigger proponents of ingredient and hazard-based disclosure for
products. The value of what a chemical supplier produces lies within the formulation of
their product, whereas the overall assembly and design of a chair, for example, is what
makes it special. Suppliers capable of creating chemicals higher up in the supply chain
are less likely to want to disclose granular information. Green building certifications are a
large driver of material health program engagement, but many manufacturers are
engaging despite lacking the demand they might need to defend the amount of time and
money it can require. Many feel they need to see the demand and market recognition to
justify their efforts, and outside of these early adopting manufacturers, there will likely
need to be a better marketable and financial case for engagement. This means that
identification of barriers to further engagement and finding large-scale solutions are key
for driving broader adoption.
Some major barriers exist to final manufacturer disclosure of product makeup using
voluntary material health programs. One of these barriers is a dearth of information from
their supply chain. Complex supply chains, and suppliers uncomfortable with disclosing
what they consider to be proprietary information, or trade secrets, prevent many
manufacturers from being able to participate in programs that require a significant
amount of disclosure, like Declare. Another major barrier is a lack of education, both for
suppliers, and for consumers.
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More education for suppliers around the purpose and application of the information
requested would perhaps increase their comfort level with disclosing. Greater education
for consumers around the purpose of each program, and how to interpret the information
provided by each program would make the final manufacturers and their suppliers more
confident in the benefits of participation and might ease fears about misinterpretation of
complicated hazard information in programs like HPD. The movement is very much in
its infancy, and beyond the leaders in the industry, this education also needs to extend to
other manufacturers in the industry.
Another large barrier is a lack of standardization in how material health information is
defined, gathered, communicated and interpreted. The more that the industry can speak in
a common voice, the more consistent the demand and response for information will be.
Currently, manufacturers are requesting information from their many suppliers, and
receiving the requested information many different ways. Their suppliers are being asked
for lots of different information to feed different programs using different formats.
Flexibility is important to allow suppliers to provide information in a manner that suits
them, just as having multiple programs is important for allowing final manufacturers to
pursue an avenue that fits their model. However, if programs align enough so that
manufacturers request the same common baseline of information from each supplier, the
work will become easier for all parties involved. Even the definition of an ingredient can
be unclear at this time.
Another potential solution is to eventually create, or adapt, material health programs that
begin collecting data upstream with suppliers, and aggregate that information down the
supply chain. This would reduce the redundancy of information requests, potentially also
reducing the time it takes to make progress and the cost of engagement with programs.
Alignment of how programs interpret risk and exposure from products chemicals will
also serve to increase confidence in the output of programs. While differences in the
programs do serve the market by offering different levels and methods of engagement,
inconsistencies in all of these stages of material health assessment should ultimately
decrease in order to speak with a common voice to a larger audience.
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All of these improvements will also serve to reward engagement with these programs.
Greater harmonization, alignment, and clarity around material health programs will
increase demand and will reward the manufacturers who have chosen to engage.
Continued movement beyond solely list-based approaches, to full assessments of product
content, is important for encouraging better-informed changes. Lastly, material health is
not a siloed issue. Changes made to product chemistry affect other attributes, and may
cause tradeoffs in other environmental properties. Multi-attribute thinking, and therefore,
multi-attribute programs or databases that aggregate life cycle and material health
information, will allow for better decision-making based on the needs of the consumer.
Most participants felt market-driven solutions were the fastest path to a healthier
materials market, both within the interviews and the surveys. None were entirely opposed
to increased regulation, though interviewees expressed their skepticism that better
regulation was a possibility. Many felt this might allow for a more “level playing field”
and increased standardization around disclosure and interpretation. However, even if
enough compromise can be found to allow for the passage of better regulation, regulation
is more likely to remain a “trailing indicator” of where market direction. Market-driven
solutions are the most likely, and most efficient, route to a better market.

5.7

Comparison to Literature

Existing literature looks primarily at flows of chemical, hazard and risk information in
consumer product supply chains.
Supply Chain Complexity + Proprietary Information
Supply chain complexity “matrix within a matrix” have been shown here and in the
literature to be a significant barrier.
… it is safe to assume that if we should trace all actors of a supply chain for a
company that is near the end-consumer in the product chain, we will often end
up with a large number of individual companies, even if the range can be
considerable, from below ten to, possibly, millions, depending on the size and
the nature of the company we take as our starting point. (Kogg & Thiddell,
2010)
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This research parallels research by Scruggs and Ortolano (2011) on information barriers
to safer products, that proprietary claims and information lost in complex supply chains
were one of the main challenges facing European manufacturers in trying to comply with
REACH regulations. However, this current research looked more closely at the
perspectives of those manufacturers, and underlying reasons for lack of ingredient
disclosure. Voluntary material health programs have been a smaller focus of other papers
to date, likely as the adoption of these material health programs is relatively new.
As in Scruggs’ paper on reducing hazardous chemicals in consumer products (2013),
actions by manufacturers are still being done on an individual basis, therefore plenty of
‘reinventing of the wheel’ is taking place. Lack of a standardized system for data
collection may prevent other companies from engaging at this point.
Fransson & Molander (2012) found that information was generally not traveling more
than one tier up or down in textile industry supply chains. In the current research, some
manufacturers described having to gather information 3 or 4 tiers back in their own
supply chains. Red lists were found to be used most commonly in both studies for
communication of product content.
Levels of Appropriate Information
Fransson (2013) also looked at consumer paint supply chains and the use of SDSs in
communicating hazard information. The communication of appropriate levels of
information for each stakeholder was found to be very important where risk is concerned.
This current research emphasizes the need for information beyond SDSs and risk
information, however it also found that the distribution of appropriate information to
different stakeholders is important for decision-making. A rating system for products,
that uses a transparent standard may allow consumers the ability to make simple
decisions and recognize the safety of a product, while allowing them to research the
justification for a rating if they desire additional information.
In their assessment of stakeholder chemical information needs, Kogg and Thiddell (2010)
identified two critical tiers of information. Tier 1 information focuses on the chemicals in
a product, and which chemicals have the potential to migrate from the product in certain
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life cycle phases of the product. This information should be harmonized within an
information system. This aligns with findings from this current research that greater
harmonization and standardization of information collection will be beneficial. Tier 2
information, the interpretation of this information and instructions for action, aligns with
this current research’s evaluation that program interpretations of chemical content can
continue to compete. Tier 1 collection about ingredients should be harmonized
“and…this information should be supplemented with the tier 2 kind of information as
tailored support functions to be adjusted and harmonized by and for certain stakeholder
groups/sectors sharing similar needs” (p. v).
The emphasis on hazard prevention rather than risk management is also aligned with
Rossi (2015) and argues for a programs that address material health further up in supply
chains, and aim to eliminate hazard rather than relying too heavily on risk and exposure
assessments to show that a product is safe.
The implementation of CiP information systems that enable downstream
actors to factor in the content of chemicals (of concern) in their buying
decisions will enable policy makers to harness the forces of the market to
contribute to put pressure on the upstream chemical industry (Kogg &
Thidell, 2010, p. v)
5.8

Limitations

There were a number of limitations in this research, in addition to limitations outlined in
the first chapter. Due to the exploratory nature of the study, and the limited number of
participants, extrapolation of the results to the larger industry is not possible. In addition,
the survey was quite broad in its scope. The research would have benefitted from a
narrower focus aimed at quantifying a few of the answers to the research questions. The
questionnaire, however, may provide a starting point for future research on manufacturer
perspectives.
Samples for both interviews and surveys were not representative of all building product
types. Therefore, perspectives from those sectors may have been missed in the results. A
larger sample size for surveys would also be useful as a follow-up.
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Broad themes were pulled out of the interview results and surveys, and a list of barriers to
program adoption and information disclosure was identified. However, ranking of these
barriers was not possible. More pointed questions that asked participants to rank a select
number of barriers might be useful to determine which issues to tackle first.
Another difficulty was in the ability to compare three programs that function very
differently. Future research might group material health programs by their function rather
than solely their incorporation into other standards in order to better separate issues of
how programs assess material health and how that affects adoption.
History of engagement was also important to the manufacturers. Many reported
unfavorable interactions with some of the programs in early pilot phases and were
reluctant to engage again, even if some positive changes had been made. It was also
generally difficult to separate which results reflect the perspective of the participant and
which reflect those of the company as a whole. Personal perspectives, company sector,
company mission and a number of other factors mentioned in section 4.6 could have had
an influence on survey and interview responses.

5.9

Recommendations for Future Research

The broad nature of this study was useful in a field that has not been written about much
in the academic literature. Part of what this study attempts to communicate is the
complexity of the situation in order to draw attention to the need for solutions to solve the
pressing issue of how we create a healthier materials market. However, the breadth of a
study naturally limits the depth with which it can explore particular issues. There would
be much utility in exploring more deeply each of the barriers identified by this research.
One possible study could use manufacturers as case studies to assemble a list of best
practice methods for overcoming the barriers outlined in this research, and compare these
to findings on best practice for chemicals management in consumer products by Scruggs
(2013).
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A study that focuses on suppliers near the beginning of the supply chain, including raw
material and chemical suppliers would provide a useful measure of comparison to final
manufacturers. There would also be value in studying individual supply chains in order to
examine suppliers at every stage of the supply chain. An interesting study might study a
few final manufacturers with complex supply chains in order to determine their specific
barriers and how they are overcoming them. The format of transfer of information
between different manufacturers, paired with supplier perspectives on transparency and
disclosure would be particularly useful to learn more about barriers over multiple tiers of
supply chains. Studying supply chains that bridge different industries and therefore may
be subject to different regulation both globally and domestically, and different consumer
demands and supplier perspectives, would also be interesting.
There would also be use in looking at a few sectors within the building products industry.
Ultimately, what works in terms of transparency for a coating manufacturer may not
serve the maker of a chair. Another interesting study might compare the approach found
within the building products industry to barriers and solutions present in other industries
such as the auto, beauty, or food industries. It is easy in many ways to draw parallels
between the building products industry and other industries—to point to the auto industry,
to look at the push for better ingredients in cosmetics, the organic food movement.
However, there are particular complexities present in the building products industry that
complicate the issue, not limited to complex life cycles, different building purposes
(children’s school vs. storage warehouse), differing exposure to interior vs. exterior
products, and supply chain complexity.
A review of programs that are beginning the data-gathering process at the top of the
supply chain with raw material suppliers and chemical suppliers would allow further
insight into how this approach is working, and how realistic it is to expect disclosure of
information down the supply chain.
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5.10 Chapter Summary
This research was designed using relevant literature and by engaging with key
stakeholders in the building product industry. Though the ability to extrapolate the
research beyond the sample studied is limited, the research questions set out were
answered and industry contact confirms the importance and relevance of this work.
Manufacturer perspectives on material health programs and issues of disclosure and
transparency were studied in order to determine barriers and solutions to further adoption
of programs and thus the release and analysis of further chemical information in the US
building products industry. The main barriers and potential solutions to those barriers
were discussed. Recommendations for future research with a narrower scope that
explores some of the themes identified in this research were presented.

REFERENCES

100

LIST OF REFERENCES

Akadiri, P. O., Olomolaiye, P. O., & Chinyio, E. A. (2013). Multi-criteria evaluation
model for the selection of sustainable materials for building projects. Automation in
Construction, 30, 113–125. http://doi.org/10.1016/j.autcon.2012.10.004
Basu, S., & Bidanda, B. (2014). Shortcomings of Eco-labelling of construction and
building materials (pp. 151–165). Elsevier.
http://doi.org/10.1533/9780857097729.1.151
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology, 3, 77–101.
http://doi.org/10.1191/1478088706qp063oa
Espinoza, O., Buehlmann, U., & Smith, B. (2012). Forest certification and green building
standards: overview and use in the U.S. hardwood industry. Journal of Cleaner
Production, 33, 30–41. http://doi.org/10.1016/j.jclepro.2012.05.004
Fransson, K., Brunklaus, B., & Molander, S. (2013). Flows of Chemical Risk Information
in the Consumer Paint Product Chain. Journal of Industrial Ecology, 17(2), 310–320.
http://doi.org/10.1111/j.1530-9290.2012.00542.x
Fransson, K., & Molander, S. (2012). Handling chemical risk information in international
textile supply chains. Journal of Environmental Planning and Management,
(APRIL), 1–17. http://doi.org/10.1080/09640568.2012.681032
Golafshani, N. (2003). Understanding reliability and validity in qualitative research. Test,
8(4), 597–606.
Heine, L., Kausch, M., Klosterhaus, S., Glass, S., & Lent, T. (2013). Material Health
Evaluation Programs Harmonization Opportunities Report, 1–32.

101
Hoffman, A. J., & Henn, R. (2008). Overcoming the Social and Psychological Barriers
to Green Building. Organization & Environment (Vol. 21).
http://doi.org/10.1177/1086026608326129
HPDC. (2015). Health Product Declaration Open Standard. Wakefield, MA. Retrieved
from http://hpdcollaborative.org/standard-documents/hpdstandard_v1_0_121215.pdf
ILFI. (2014). Living Building Challenge 3.0. Canada.
Isnin, Z., Ahmad, S. S., & Yahya, Z. (2012). Challenges of the Unknown Building
Material Substances for Greener Adaptation Projects. Procedia - Social and
Behavioral Sciences, 68, 53–62. http://doi.org/10.1016/j.sbspro.2012.12.206
Jackson, T. (2009). Prosperity without growth: Economics for a finite planet. London:
EarthScan. Retrieved from
http://www.gci.org.uk/Documents/Tim_JACKSON_Prosperity_Without_Growth.pd
f
Kamrin, M. A. (2014). Regulation, Toxicology and. Encyclopedia of Toxicology (Third
Edit, Vol. 3). Elsevier. http://doi.org/10.1016/B978-0-12-386454-3.00426-7
Koch, L., & Ashford, N. a. (2006). Rethinking the role of information in chemicals policy:
Implications for TSCA and REACH. Journal of Cleaner Production, 14(1), 31–46.
http://doi.org/10.1016/j.jclepro.2005.06.003
Kogg, B., & Thidell, Å. (2010). Chemicals in Products: An overview of systems for
providing information regarding chemicals in products and of stakeholder’ need for
such information, (August).
Kokai, A. (2014). The Public Ethics of Green Design Tools in the Building Industry.
Lee, Y. S., & Kim, S. (2008). Indoor Environmental Quality in LEED-Certified
Buildings in the U . S ., (November), 293–300.
Long, T., & Johnson, M. (2000). Rigour, reliability and validity in qualitative research.
Clinical Effectiveness in Nursing, 4, 30–37. http://doi.org/10.1054/cein.2000.0106

102
Lowell Center for Sustainable Production. (2008). An Analysis of Corporate Restricted
Substance Lists ( RSLs ) and Their Implications for Green Chemistry and Design for
Environment. Green Chemistry & Commerce.org.
Lowell Center for Sustainable Production. (2009). Gathering Chemical Information and
Advancing Safer Chemistry in Complex Supply Chains. Green Chemistry,
(September).
Markell, D. (2010). New Directions in Environmental Law : An Overview of TSCA , its
History and Key Underlying Assumptions , and its Place in Environmental
Regulation. Washington University Journal of Law and Policy, 32(January), 333–
375. http://doi.org/10.2139/ssrn.1616674
Ogunkah, I., & Yang, J. (2012). Investigating Factors Affecting Material Selection: The
Impacts on Green Vernacular Building Materials in the Design-Decision Making
Process. Buildings (Vol. 2). http://doi.org/10.3390/buildings2010001
Pacheco-Torgal, F. (2012). Toxicity of Building Materials. In Toxicity of building
materials (pp. xv–xvii). Woodhead Publishing Limited.
http://doi.org/10.1016/B978-0-85709-122-2.50019-X
Scruggs, C. E. (2013). Reducing hazardous chemicals in consumer products : proactive
company strategies. Journal of Cleaner Production, 44, 105–114.
http://doi.org/10.1016/j.jclepro.2012.12.005
Scruggs, C. E., & Ortolano, L. (2011). Creating safer consumer products : the information
challenges companies face. Environmental Science and Policy, 14(6), 605–614.
http://doi.org/10.1016/j.envsci.2011.05.010
Scruggs, C. E., & Van Buren, H. J. (2014). Why Leading Consumer Product Companies
Develop Proactive Chemical Management Strategies. Business & Society.
http://doi.org/10.1177/0007650314536393
Turner, D. W. (2010). Qualitative Interview Design : A Practical Guide for Novice
Investigators. The Qualitative Report, 15(3), 754–760. Retrieved from
http://www.nova.edu/ssss/QR/QR15-3/qid.pdf

103
van Teijlingen, E., & Hundley, V. (1998). The importance of pilot studies. Nursing
Standard : Official Newspaper of the Royal College of Nursing, 16(35), 33–36.
http://doi.org/10.7748/ns2002.06.16.40.33.c3214
Waage, S. A., Geiser, K., Irwin, F., Weissman, A. B., Bertolucci, M. D., Fisk, P., …
McPherson, A. (2005). Fitting together the building blocks for sustainability: a
revised model for integrating ecological, social, and financial factors into business
decision-making. Journal of Cleaner Production, 13(12), 1145–1163.
http://doi.org/10.1016/j.jclepro.2004.06.003
Wilson, M. P., & Schwarzman, M. R. (2009). Toward a new U.S. chemicals policy:
Rebuilding the foundation to advance new science, green chemistry, and
environmental health. Environmental Health Perspectives, 117(8), 1202–1209.
http://doi.org/10.1289/ehp.0800404

APPENDICES

105
Appendix A

Interview Guide

MANUFACTURER INTERVIEW GUIDE
Introduction:
Thank you very much for taking the time to participate in this interview. This research is
being conducted as part of my Master’s thesis at Purdue University. Your participation is
voluntary and you may choose to end the interview at any time.
The purpose of this interview is twofold. First, I would like to learn how the introduction
of material health evaluation programs is changing the communication of material hazard
information in the building material supply chain. Second, I am interested in how how
changing standards of material health are impacting relationships between manufacturers
and other key stakeholders in both supply and demand chains.
[Your company] has demonstrated awareness of, and experience with evaluation of
product material health. I wanted to speak with you to learn more about your experience
working with these programs and your company’s approach to material health and
disclosure.
I will be recording this interview to improve the accuracy of my notetaking. This
recording will be used for transcription purposes only. The audio recording will be
deleted after transcription, and the notes will be deleted upon completion of this project.
Your responses will remain anonymous and no individual or company names will be
used in any published results. Please let me know if you would prefer that I not audiotape
this interview. The interview should not last longer than 45 minutes - 1 hour.
This project is focused on the health and toxicological properties of materials. Therefore,
I would like to limit the discussion to your knowledge of Material Health programs, and
avoid purely environmental tools like Environmental Product Declarations. “Programs”
will refer to the main health evaluation and declaration programs that are commonly used
in the industry, such as Health Product Declarations, Cradle to Cradle, and Declare.
Do you have any questions or concerns before we start?
Program Use:
1. Please briefly describe the role of your company in the building supply chain (e.g.
supplier of parts, manufacturer of final products, etc.), as well as your role within
the company.
a) What does your role [mean] with respect to your company’s compliance
with these programs?
1. Do you see your role in this process as temporary or do you see it
changing more?

106
b) Which of these programs has your company pursued for products?
1. Has your company pursued any other health
certification/evaluation programs?
2. Why are you pursuing that and not the others?
2. Different manufacturing sectors are confronted with different challenges with
respect to disclosure and ingredient toxicity. What do you feel are important
barriers to the evaluation/certification of products? Are any of those challenges
(barriers) sector-specific?
If they have done C2C:
3. [Could you describe for me the process of complying with C2C certification?]
a) What have been the internal benefits of using a 3rd party assessment
program?
1. Do you think the NDAs are necessary to obtain those benefits?
b) What were external benefits that you’ve experienced with your
stakeholders?
If they have done HPD and/or Declare
4. [How does this process compare to an HPD or Declare label?]
a) What have been the internal benefits of self-declaring ingredient
information?
b) What were external benefits that you’ve experienced with your
stakeholders?
5. What have you learned from gathering all of this information [from your supply
chain]?
a) How does the certification change what you learn?
Internal:
6. Has your company developed any additional in-house tools to facilitate gathering,
communication or interpretation of chemical information?
a) If so, why and what do they do for you?
7. What is your impression of the red list/screening approach prevalent in material
health evaluation?
Ideal program:
8. Could you describe for me what you ideal program might be? Multi-attribute,
single ingredient chemistry, product-level chemistry, transparency based?
Stakeholder Relationships:
[Supply chain]
9. How, if at all, have program requests changed the structure of your supply chain?
a) Have they changed your relationship with suppliers? Why or why not?
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b) Are these changes fairly localized to certified/evaluated products or
throughout?
c) Do you see these changes working themselves into a wider range of
products in the future?
10. How would you like to see the flow of information between your company and
suppliers improved?
a) What types of changes to the process of requesting information from your
supply chain would allow you to certify more products?
[Architects]
11. How, if at all, has implementation of these programs changed your relationship
with architects?
a) How do you see this relationship continuing to evolve in the future?
12. What type of data do you find is most valued by architects? What do you think is
most useful to them? What do you think they need to inform their decisionmaking?
13. How do you use HPDs? Internal document? External?
14. How about with Consumers?
[competitors]
15. Lastly, I’m interested in how program requests have changed your relationship
with your competitors?
a) Have these programs promoted information sharing between you and your
competitors?
b) Is increased information/data sharing a reality in your sector? Across
sectors?
Transparency:
16. What does transparency mean to your company?
17. Is transparency necessary for a healthier materials market?
Other:
18. Is there anything else you would like to discuss or mention beyond what we have
spoken about?
19. Who else should I talk to?
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1

2

3

4

5

6

Participant-Given Transparency Definitions

“[Recognizing] man’s simple nature to not change anything, to not upset the apple cart, there does
need to be some transparency. I don’t’ think it needs to be the be-all-end-all. It can destroy trade
secrecy. It can destroy originality in some senses. But I think there needs to be some to an extent. I
don’t know what that extent should be. The ultimate safety of your users should come into play but I
don’t know whether it should be the guard of whether something goes to market or not. If you have
a cd that says “explicit language” – buy it at your own risk. Same with products. I think that’s
beneficial.”
“Now there is a race to the top- I want to be the “transparentest”...That is generally a good thing. I
believe transparency is the foundation. How we then do the assessments for what has been
disclosed…is now even more in its infancy than standardizing what transparency means… but that is
undoubtedly a good thing.”
“If it’s relatively easy, transparency can make it happen even without getting to market. The more
difficult stuff will probably take more pressure.”
“So I think that’s where looking solely at transparency – it’s a great start but there needs to be more,
it needs to be stronger, there has to be that continuous improvement.”
“I don’t buy into that if you put it out for everyone to see, you will clean it up, because that’s not
what we see in the marketplace. We’ve seen people put out an HPD and people say “Thank you”
and they check the box.
“I would kind of answer ‘No.’”
“Having said all that though, I think if there is a level playing field for transparency, I think it could
potentially move the market because competitors in different industries would be looking at each
other’s disclosures and potentially figuring out where the common issues are or where someone else
has made improvements. But that also presents problems of, what’s the benefit of innovating if
everyone can just take your idea, so you get some of that issue too, there are some interesting
opportunities, I just don’t know if its there yet.”
“You can’t really be transparent without being really honest and thorough. I know that there are a lot
of organizations that would view- ‘oh there’s not XYZ in it’ as being transparent. But I think we
really need to move towards a model that is, being completely transparent before we are really able
to make significant changes in what we’re using. We need to have some pressure. I need to be able
to put pressure on my suppliers …as long as there is a way to hide behind not being fully
transparent, I don’t think that can happen. I think we’re a long ways out before all manufacturers
embrace transparency. But I hope that the market will reward the folks that do.”
“Yes, yes. I would definitely say yes. Because it brings- it gets people thinking about what they’re
putting in their products and what they want the public to see about what’s in their product. And it
drives people to making better choices, and everyone is always looking for those better options…but
I think just putting it out there makes people think it over twice.
I think the other thing that it does is- it drives a harder conversation of getting that information from
our supply chain. So while we’re being asked to be transparent, we need to be sure that we are
telling people the right information. And if we don’t know what’s in our products, we can’t do that.
So it forces us to tighten up our information-gathering practices from our supply chain, which, as
I’m sure you’re aware by now, is not easy. It’s really difficult to do.”

7

“The first thing that came to my mind was the HPD vs. C2C. I can tell you everything, all the
materials down to 1% or less as a threshold (which is where all the difference makes in that special
sauce that makes the differentiation in the product). And that’s fine, we don’t want to give trade
secrets. Is that better than giving it to C2C and they put it in their black box and magic machine and
it turns out gold, platinum, bronze certification? I don’t know.”
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8

9

10

“Transparency on its own doesn’t do anything.”
“So yes, it’s very important, but I’m afraid that that’s only one piece of it that is important. The rest
of it is making sure people understand it.”
“If the market wants transparency and we as manufacturers want to sell into that market, we need to
work something out. That being said, we’re not just gonna do what all the NGOs and what one
faction of the world wants. We’re going to do what is scalable and what the industry at large can
do.”
“I think transparency in a vacuum, it’s a starting point because you have to have it to do some of the
other things in some regard, but there’s also different ways to deliver that. You have to consider
things Intellectual Property and who are you telling these things to and why do they need to know
and it’s obviously a very complicated subject.”
“I think I had a better- maybe a more confident answer- maybe 2 years ago. Now I feel like, I don’t
know anymore where the industry is gonna go.”
“I know we need disclosure or transparency but I want to balance it with productive changes.”

11

“So I’m a full blown proponent. We’re exposing ourselves to stuff and the government’s not going
to say it. So I want to know everything and I want to disclose everything and I want things to be as
healthy as they can possibly be.”
“as people have started to become more aware of these things through disclosure of ingredients and
the health impacts of them, it changed the market significantly and this is gonna be no different. “

12

“I want to be transparent; I think it’s great. But as we discussed, in practice that is a very difficult
thing to do. And I’m not sure that companies are willing, or have the ability, to be transparent. It
depends on the company, right? But it’s just very difficult, and it’s going to take a long, long time to
get there. I think the writing’s on the wall. We need to be transparent; we need to know what’s in
our products.”
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Appendix C

Interview Summaries

INTERVIEW 1
Growing interest in material health/transparency
Growing attention to material health from customers
Transparency as differentiator for companies
Growing demand for chemical information from consumers
Need for Education
Need for education around transparency
Industry learning curve (lead wasn’t put in there to harm people)
Purpose to ‘nasty’ chemicals
Buy at your own risk, if knowledge of contents and risks
Importance of decisions/education being carried down the chain (to contractors- otherwise, a lot of work for nothing)
Level of Transparency
Difference between transparency and revealing the product formulation
Drawing the line in how much transparency is reasonable
Transparency + conversation of comparison
Limits of transparency
Program Pros + Cons
HPD provides a clearinghouse of materials and transparency
High cost of programs/testing can be a deterrent
Qualifying Hazard, Risk
Qualification of hazard
Hazard vs. risk
Practicality: anything, any substance can kill you in the right circumstances
Context (encapsulated materials, bound materials, circumstances) affect risk
Communicating Product Information
Hazard warnings can scare off consumers for the wrong reasons
Approach to Making Products
Perception that you can make green products without expensive certifications
Barriers to Obtaining Information
Proprietary Information
Difficulty of gathering information higher in supply chain
Trade secrets up supply chain
Further up supply chain there is more to set a material apart (PI)
Communication Gaps/Errors
Not using threshold in requests from suppliers (accuracy of info?)
3rd party verification importance
3rd party verification helps manufacturer confidence in information
Work with verifier to understand proprietary information

INTERVIEW 2
Importance of Transparency
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Transparency can have delayed positive impacts, by making the manufacturer think about what they are giving to their
customers
Transparency can change the market by itself if it’s easy
Difficult changes will take more than transparency
Seeing a race to the top to be the “transparentest”
Transparency is the foundation of material health
Transparency-based tools alignment with company philosophy (setting an example)
Ingredients level approach to transparency is important
Partial disclosure is better than nothing
Programs may be smokescreens, but pressures manufacturers to do more in future
Despite lack of publishing, stresses early involvement in programs/pilots
Industry shared supply chains mean proprietary ingredients often aren’t secret
Language of Transparency
Need to develop the language of transparency
We should rate how transparent you are before we rate hazard
Disclosure vs. Real Transparency
Manufacturers know better in some situations- i.e. when a CAS# is misrepresenting an ingredient
Hard to drive change if changing paperwork is done over changing a product
Ingredient/Product Assessment is in its infancy
How we assess what is disclosed more in infancy than standardization of transparency definition
Problems with Existing Standards
Desire for transparency of standards
Importance of transparency-based standard
Difficulty of working with NGOs for long periods of time
Compliant or noncompliant Red List approach encourages lying
Tying transparency program to a green building standard encourages manufacturers to lie
Potential issues of binary status (in or out) with material health
Many manufacturers are too comfortable lying, even just a little bit
Overall frustration with how programs are unfolding
If you have to label all products as hazardous, can’t find the ones that aren’t
Cost as barrier to program participation
We are building on imperfect systems like CAS#
Desire for transparency around Red List formation
Program output/Labeling
Having to label your product as hazardous when it is not
Hazard vs. Risk
Risk assessment is imperfect, not a panacea for hazard approach
Hazard systems describe their products as toxic, which they disagree with
EPDs help to feed HPD information (ingredient information)
Need for regulation
Chemical regulation is failed and broken
Electronic waste as example of where regulation would have been better than state rules
Industry groups hang on program issues (titanium dioxide, silica, etc)
Political advocates want to throw out programs because a few parts don’t work
Mishmash of NGOs and corporate buyers and statement requirements, hugely complicated
Predicts people will be begging for regulation to simplify
Need to balance priorities
Perfect chemistry as barrier to recycling (competing/tradeoffs of sustainability)
Immediacy and fear around health topic, but need to take a more holistic approach to products
Verification
3rd party verification needs a standard
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INTERVIEW 3
Transparency alone is not enough
Pure transparency standards do not go far enough
Transparency is not enough to catalyze change
Pure transparency standards externalize selection of safer products to customers
Architects don’t have time or expertise to understand HPDs
Standards should be transformative and require change
3rd party disclosure is very important for better understanding of product
C2C is expensive but worth it for what it offers
Sustainability is not single-attribute
Material health alone as a cause is insufficient
It will be a long time before suppliers are begging to disclose
Proprietary Information
Not all supply chains are ready to disclose
3rd party verification allows for more granular information
Full formulations held tight by suppliers
Evaluation of Standards/Programs
Free and open standards allow for greater involvement by broader set of manufacturers
Products are being selected because of HPD purely to check the box
Consumers may have a preference for one program over another
Need for education around standards
Lots of education at conferences going on to help architects understand standards
Changing Industry / Commerce drives change
Ingredient/health considerations are here to stay
Opponents to industry change are trade groups, not customers
Manufacturers should listen to their customers, this will drive change
Certifications aren’t changing the market, the market created the certifications
Demand creates transformation
Commerce drives change (Exchange dollars for better products, manufacturers listen)
They have made some supply chain changes
Industry Efforts
Example of manufacturers working in groups to push down supply chains
Aggregated power- work together to make change

INTERVIEW 4
Supply Chain Education
Working with suppliers up to 6 tiers deep in supply chain
Lots of education efforts
Engaged 400 of 1200 suppliers
Approach to Safer Products
Proactive approach to product design
Avoiding materials they don’t want through their engineers
Internal ‘priority materials of concern’ list
Proprietary Information in Supply Chain
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Suppliers hold information proprietary
Proprietary supply chains can prevent participation in programs
Disclosure-based programs vs. assessment-based programs
Company has historically focused on assessment
Suppliers can increase or decrease up supply chain
Difficulty Gathering Information from Supply Chain
Share supply chains with residential furniture and auto industry
If they ask for something different than bigger industries, will be dismissed
NDAs put in place by suppliers
Suppliers don’t want another account (HPD builder, anything)
Need to be flexible with suppliers in order to successfully gather data
NDAs can still point to hotspots of material issues
Supplier reluctance to share information depends on situation
Importance of 3rd party certification
Want your certification to mean something to the market (C2C does)
3rd party certification = stamp of approval outside their company
Difficulty of Replacing Problematic Materials
Replacing problematic materials (3 methods)
Developing new materials can be really challenging
Need for Consumer Education Check the box mentality
Inability of architects to interpret HPD
Architects using HPDs to check a box
Need for Standardization of Disclosure (/Innovator’s Dilemma)
Level playing field for transparency could move the market
Does a level playing field destroy innovation?
Transparency vs. disclosure
Innovator’s dilemma- don’t want to be first
Disgusted by lack of ingredient representation on some labels
Until they can disclose fully, don’t want to discslose at high level
Conservative companies don’t want to make claims they can’t back up
What kind of transparency serves us? Format of disclosure
Can we really interpret food labels? (even PhD in inorganic chemistry)
Hazard vs. risk issues
Nutrition information vs. ingredients (high carb, etc)
Need for Standardization of Interpretation (not just education)
Interpretation of disclosure/transparency is not constant
Everyone is interpreting full ingredient disclosure differently
The manufacturer that is the most transparent has the worst looking product
Importance of Proprietary Information
Reverse-engineering to determine what is in products
Hazard vs. Risk
Importance of Easy Product Line Certification (scalability among products)
Many different groups have their own RSLs
C2C allows for easier product line certification (allows for exclusions)
Brand recognition can be the most important (i.e. Patagonia vs. Nike)
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INTERVIEW 5
Getting good information from your supply chain is generally very difficult
Vast majority of experiences getting information from supply chain are difficult
Knowing the supply chain and working directly with them helps
Chances of getting information is slim
Chances of getting correct information is rarer
Tons of room for improvement in flow of information in supply chains
Supplier lack of understanding around what to disclose
Supplier lack of care in accuracy
HPD is an avenue for better communication
Barriers to Disclosure
Getting good information from your supply chain
Multiple suppliers for same components
All products are custom, still making disclosure difficult despite product simplicity
Recycled content is a big issue- how to report it
Chaos, confusion, and burden of data management for companies with many suppliers and SKUs
As long as you can hide behind not being fully transparent, there will be no pressure to change
Will always be leaders and laggards in all areas (including material health)
Disclosure is very important
Disclosure is incredibly importance (outlier)
Attention to material health is an important part of the evolution of the industry
Need to “clean ourselves up a bit”
As long as you can hide behind not being fully transparent, there will be no pressure to change
More regulation is welcome, but market-driven solutions will be faster
Lack of Risk vs. Exposure Acknowledgement in some standards is a problem
Understands concerns about risk v. exposure
Not enough weight given to production and disposal in risk assessment
Motivation for Disclosure
Believes transparency is still the best
The fact that you’re willing to disclose should signal you are doing the right thing
Going after certifications/standards even without real demand for them
Helps company to communicate their commitment to sustainability
Hopefully the market will reward those who embrace transparency
Different Program Attributes Allow for Greater Overall Participation
HPD allows you to list hazards without CAS, allowing for protection of IP
Cost as deterrent for C2C, other areas to spend money in
Cheap and free standards level the playing field so smaller companies can’t get shut out
C2C is the easiest to use, so as a user that would be preferable
Not as much demand for HPDs/labels yet
Manufacturer spending more time explaining what an HPD is than being asked for them
Expectation that demand for HPDs will rise
Education is a big, important task
Manufacturer spending more time explaining what an HPD is than being asked for them
Expectation that demand for HPDs will rise
Appears HPDs are being collected just to “check a box” for compliance
People don’t know what to do with HPDs yet
There is a lot of education to do in the marketplace
Labels can get very confusing, and greenwashing happens
Comes down to a need for education around what is being specified
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Industry is starting to pay more attention to what they put in things (and it’s time)
Internal conversation is expanding for manufacturers – from energy to chemical related issues
They haven’t yet targeted their chemicals, but many they’d like to get rid of

INTERVIEW 6
Different businesses in companies have different regulatory and customer requirements
Some companies have consumer-facing businesses, but also ones that don’t face customers
Each business owned by a company may have a different regulatory climate
Different businesses owned by a company may have different consumer need
So company may have many different industries, needs, wants to juggle
Ubiquity of Chemicals
Everything is coated with something
Drivers of Change
Building products driven by green building standards
Residential interiors driven by purchasing by Loewe’s, etc
Type of Disclosure – input ingredients vs. cured product
Disclosure of wet applied vs. baked on coatings
Input materials vs. final product disclosure
Red List Benefits
Red Lists and HPD are driving internal conversations about avoiding CoC
Red List approach is actionable and scalable
Red List Issues
Intellectual property is important – particularly for formulations
Fear of expanding Red Lists
Is disclosure feeding new restricted substances lists
RL can result in regrettable substitutions- overhead conversation about substituting worse chemical
Communication with Suppliers
Communication with their suppliers is often through a letter or email confirming RL free
Want to compile their own internal CAS#s, beyond RL for all chemicals they are concerned with
Likes the idea of reportable lists – tell us if it’s in there, we will still buy it, better than just absence
Supply Chain Structure/Variability
Company isn’t tied to suppliers, based on price
Highly variable, large supply chain.
Size/variability of supply chain makes it difficult to confirm material content
Pitfalls of price-based approach.
Have begun to consolidate supply chain to have better purchasing control
Want to hold suppliers accountable for formulations and preference to transparency
Want more trust in supply chain
Need more supplier education
Disclosure Information/Format
Non-toxicologists have a hard time understanding disclosure requirements and output
Difficult to determine how you measure up in an HPD
Data Gathering/Management
Plan is to annually updated internal CAS list, and contact manufacturers minimum of every 3 years to update disclosure
(cycle of standards)
Hazard vs. risk criticism of HPD
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Scalability of solutions
California safer consumer products regulation- alternatives assessment- was expensive and slow
Tradeoffs in impacts- Life Cycle vs. Material Health
Tradeoffs- life cycle impacts vs. material health
Need to have human decisions to weigh tradeoffs
Consumers drive manufacturing changes
Manufacturers driven by what consumers want.
Voluntary programs help employees push material health and transparency internally
Why Transparency Matters
Transparency is necessary because it gets people thinking about what they put in products and what the public sees
Regulation is slower than market solutions
Regulations are trailing indicators for Chemicals of Concern
NGO-driven programs and state regulations, purchasing campaigns are leading indicators
Need more conversations between trade organizations and NGOs.
By the time a chemical is regulated it’s off of their plate, they deal with proactive
Will they or won’t they stock us is much quicker than regulation
Transparency programs drive a harder conversation of getting good information from the supply chain.
Transparency in its infancy
There is a long way to go with transparency
More people are on board with transparency
Green labeling will balloon for a while
Difficulty of Multiple industries working on these issues, different asks
Programs are starting to work together in building industry, but that’s only one industry.

INTERVIEW 7
Transparency is in its infancy
Cannot compare 2 HPDs
Only recently enough HPDs to comply with LEED credit
Engaging in lots of education, need for much more
Interviewee’s company focus still largely on LCA impact
Material health not yet primary concern
Lots of internal education – customer service, marketing, corporate, global initiatives
Lots of external education – panels, white papers, speaking, trade shows, nonprofit involvement
Importance of educating the market – so they can digest the information they are given.
If we collect all this data, and no one can digest it and understand it, why is it valuable?
Chicken and egg data situation- trying to learn everything even when you don’t know how to read
Disclosure output/format
Issue with having to disclose hazards for ingredients that we know are not problematic
Do we disclose without criteria or put through black box and get a rating people can use?
Company actions based on customer requests
Tradeoffs in producing products
Fundamental lack of understanding in market around exposure vs. risk. Vs. performance. Vs. value
Life Cycle Tradeoffs: bad chemical effectiveness and product performance

117
Unrealistic to remove all synthetic chemicals at this point
Can’t say that all chemicals should come out of products
95% of all building products come from petroleum. Everything is made from oil right now.
One day we will get to renewable, organic materials, but we need to be realistic
Exposure and risk for exterior products, encapsulated materials
Base ingredients vs. final product may be 100% different
GreenScreen is single chemistry analysis
Encapsulated products may remain encapsulated, can even reuse products
Complicated, global supply chains
Supply chains are massively complicated – 3 tiers back there are “literally thousands and thousands of suppliers that
can product those chemicals and raw materials”
Can’t go back more than 1 or 2 tiers because suppliers have relationships with their own suppliers
Spiderweb of networks
Working on optimizing and collaborating with suppliers
Some suppliers are living in the dark age
Some suppliers are being asked the same questions from all angles and the “writing’s on the wall”
Better relationships with big suppliers with brand names.
Diminishing Influence Up Supply Chains
Billion dollar industry is a drop in the bucket compared to other industries their suppliers supply
The whole industry needs to make the same ask to have more power
Need main players in the industry to buy into this, to have enough power
Lack of Reliability/Variability in Supply Chain
Ordering a batch of materials from a company 3 months apart, could be entirely different material source (not like
ordering pens from staples)
Price and volume has a monumental effect- makes it difficult to prioritize only material health
HPD and EPD help with internal understanding
Tracking Information
Lack of standardization makes data difficult to track and interpret
Getting information 10 different ways from 10 different people
If you don’t start with the same data points (standardization) you will get totally different end
Red List benefits
Red Lists put a stake in the ground, allow us to establish something
Lots of progress made in past 5 years but a long way to go.
Red Lists
All of these different lists will give you different outcomes
REACH is doing a good job in Europe, but not used here
Collectively, things are moving in the right direction
Red lists were a good start, lots of room for evolution
Need for Holistic Approach/Prioritization
Need to look at project – not ingredient, product, assembly. Holistic
Different projects (hospital, school, data center, warehouse) – wouldn’t treat these the same
Do we need the building to last for 100 years, or be safe to eat?
Building owners are crucial in requesting health and environmental aspects
No longer a commodity-priced market – this is a differentiator between products
Prioritization: silica is not an issue. What we sit on and touch is bigger. Tackle most impactful first
Disclosure Interpretation/Need for Customer Education
How HPDs are being used is a really big unknown.
Some HPDs being passed directly to client, not being used for analysis
Fear of liability in disclosure
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Need for Standardization
Need standards for data collection and interpretation: we’re just going to splinter and splinter and splinter until we get
everyone back at the table
Splintering Efforts
Interest in cutting out the middle-man (nonprofits)
Nonprofit and for-profit working together- totally conflicting ideals at their core, doesn’t work
Have to have collaboration between architects and manufacturers. Declaring war doesn’t work
Cost as barrier to entry for some programs

INTERVIEW 8
Need for more internal support
Hired a chemical engineer to help with HPDs
Gathering Info from Supply Chain
Rare to find small suppliers a few tiers deep; small supplier wouldn’t be able to formulate chemistry
3,4 suppliers deep and we’re talking to BASF about a particular washer in a particular product
BASF dwarfs our entire industry, they couldn’t care less if we pull our business they wouldn’t notice
Textiles and colorant suppliers might not even disclose with an NDA
“Secret Sauce” much more in textile, colorant industries, wood laminate
Need for Supply Chain education
Suppliers ask their suppliers the wrong questions, so need to be trained, or need to ask directly
A lot of work goes into making sure everyone is comfortable with HPD process.
They have to work with the supply chain because suppliers were asking for the wrong thing
Huge spreadsheets sent back full of bad information, like the Pantone color
Easier for them to go back 4 tiers than to wait for the information
As you move back in the supply chain, portion of supplier’s business you account for decreases dramatically
Suppliers still uncomfortable with what they’re being asked for
Need for Consumer Education
Hopes we get there because it’s a lot of work, and you want to see the payoff when people understand and can use them
to make decisions.
Architects saying “I just look to see if there are carcinogens in the HPD. If there are, I don’t buy it”
Disclosure Format/Output
Can’t disclose CAS# with NDAs, but hazards are more useful anyway
Architects getting HPDs getting them because they are required, not looking at them
Didn’t publish in version 1 of HPD because it looked so bad
C2C cost barrier but cost also felt arbitrary
Heavily involved in Level
Risk vs. Hazard
Planning on having HPDs for all products
Some manufacturers want to use risk to justify use of chemicals, not as bad, maybe a truer picture
RL is simple and people can do it, but it’s limited in how meaningful it can be
Context matters so much
10 products all with carcinogens are not necessarily equal. How can you know?
HPD has taught them a lot internally.
Unless you ask, how are you going to know?
Perspective on Transparency/Disclosure
“Transparency on its own doesn’t do anything”
There is too much information
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Wants transparency standards to be better, more widely adopted, easier to understand.
Have to get really granular in disclosure for it to mean anything
Difficulties Changing Ingredients
Finding a chemical of concern in a part is the worst part of any month.
Changing ingredient, component, etc is really hard. Have to match visually.
Have been trying to find Phenol formaldehyde replacement for 7 years. 40k later, still no solution.
Data Management
Data management – want to have sustainability information tie directly into product information
When an engineer chooses a product they will choose from disclosed list of materials
Closing the feedback loop

INTERVIEW 9
Need for Scalable Solutions One of the most important issues for chemical company
“We’re not just gonna do what all the NGOs and one faction of the world wants. We’re going to do what is scalable
and what the industry at large can do.
‘boutique solutions’ are a waste of time”
Have to be able to do it across industries.
Chemical companies very heavily involved in almost everyone’s supply chain ACROSS INDUSTRIES
Having a way to report chemistry in so many specific industry applications would be ideal, and it actually would make
things cheaper. Addresses question of ‘why do my green products cost more?”
Amount of work/information- for a large company and cost of compliance can be huge
“Build a system that suppliers can play in…and then the industry can adopt it.”
Comparing Products
Importance of comparability and scalability
Need for ability to make comparative decisions.
They can compare their own products with testing within the company
Internal programs and ratings
What do consumers need to know?
“Some of the tools are too simple because I don’t know what to do with that information.
“I work for a chemical company and I can’t interpret an HPD.”
“What everybody really wants to know is: is this thing bad for me?”
Red List Pros and Cons
Precautionary principle vs. risk and exposure.
Not everyone buys into the precautionary principle, so it’s ridiculous to make everyone do it
If people want to know hazards that’s great, as long as they have meaningful information
Chemistry is complicated/Chemicals serve a purpose
“Just because something has x or y in it—chemistry is complicated—it doesn’t mean it’s bad, right?”
Chemistry is universal. It doesn’t care what it ends up in.
“Any chemical, depending on the situation, could be good or bad.”
“I’m not a scientist, but they put it in there for a reason”
Chemicals make the stuff do what it does
Transparency in its infancy/Increasing Demand for Information
Got involved early with nonprofits and programs due to connections with green building
“The people asking for materials information 3 years ago was a ‘rounding error’” (tiny percent)
This issue isn’t going away.
Transparency in a vacuum is a starting point, but there are different ways to deliver that.
Level/Type of Disclosure
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Fear of reverse-engineering “It’s a very real thing” – but if jumbled in components, that’s ok
None of the options for providing that transparency right now are great
“There is zero incentive”- to disclose in HPD because of time lag; getting replaced on a job 3 years out
Google’s proprietary algorithms vs. chemical company proprietary information
More at stake on IP side for chemical company than the cool looking chair company
More information disclosed is inevitable- but “to what extent? How far? How fast?”
Solution has to consider IP and more than the Precautionary Principle (risk); can’t cost a ton
Why tell people what’s in your product if they don’t even know what to do with it?
Waiting to see the dust settle, see what the market picks.
Representation of Products in HPDs
Air barrier interviewee would be comfortable “Lit up like a Christmas tree” in HPD from 10th of a percent of ammonia
for a pH buffer
The hazard-based approach will only scare you off from using a really good product, crux of issue
Hazard Assessment without Risk is inaccurate
Red List “sin list” – having a list generated by an architecture firm is “crazy”
Fundamentally don’t believe in red lists.
Rigorous internal toxicology assessments. “inferior” assessments done externally.
All about application and exposure
Where do we put the bad chemicals
Traffic cone vs. baby toy: everything has to go somewhere. Where is the best place to put them?
Crack a petroleum barrier, 7 blocks of chemistry are inevitable. We can’t ship it off on a rocket
We have to figure out where to put the rest of the things. Like traffic cones.
Business Drives Decisions
“We don’t necessarily care” what they make. I want to be in business
When we find chemicals or products we don’t like “Guess who’s gonna make the next thing too?”
Retail “carries a much bigger stick” than green building community
Green products exists sometimes but they’re expensive so no one buys it, and cheap option is bought by everyone (i.e.
phthalates)
Company weighs the request customer-by-customer, business-by-business
May prefer to give info to manufacturer- manufacturer is spending money with you. 3rd party is not.
Regulation Provides a Level Playing Field
NGOs want perfection from regulation. No compromise
REACH: “establishes a level playing field. No one loves regulation. Universal system.” US is wild west
If in 10 years, we have a solution people are halfway pleased with, it will be a shock.
Sees potential for regulation “we support TSCA reform. I see it happening more in codes. You can have a universal
system—REACH isn’t a transparency system but it feeds it.”
Need to work on communication
Company is not great at communication.

INTERVIEW 10
Supply Chain Issues
Many furniture manufacturers don’t even build their product at all – more like distribution
Somewhat vertically integrated. Supply chain- 70 main suppliers.
Program Perspectives
Have done C2C, then BIFMA, then HPDs last 4-5 years, but haven’t published HPDs
C2C was a “black box”. Owned by MBDC, lots of $, you don’t own the information so you can’t take it with you
C2C: chemistry thoroughness; gives framework for reporting chemistry, multi-attribute, protects IP, well packaged,
market driver.
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Level- furniture industry standard, flat price structure.
LEVEL only tells you what’s not in there, not what is: avoid heavy hitters, but not transparent
HPD might be overly detailed, C2C perhaps not enough
Barriers to Gathering Information
IP is an issue- legal teams don’t like that (BASFs won’t let you to see IP often)
Competitors have same supply chains but it’s still really difficult to ask for that same information
You may deal with different salesperson from the supplier, perhaps
Gathering information at more macro-level still
Getting information requires a lot of follow-up, a lot of education
Have tried to work with competitors to have the same data gathering template, but not so easy.
Difficulty in colors and finishes
Need for consumer education
Disclosure misunderstanding: people don’t understand what they’re reading
Some people “simply want us to go through the exercise”, which is good, but do I want to publish?
Reluctance to publish HPD on website, even though on a case-by-case basis willing to show it
Perspective on Transparency/Disclosure
Not yet pushing for full disclosure. Scale of 1-10, they’re a 5
“Right now there’s not as much demand as people think.
Demand for certifications/transparency among the thought leaders, but the people who are specifying for a project
aren’t necessarily sticking to that requirement.”
HPDs and legal issues: ‘medical liability’
Approach to Specifying Better Materials
Have an internal banned list
Often have to help supplier work with their suppliers (going to tier 2, 3)
Have gathered information for about 20% of their products
Civil chemical engineer and toxicologist on staff.
But sometimes, the PhDs in chemistry are being used wrong, only to badger supply chain
Data Uncertainty
Common assessor for two furniture companies- found out inconsistencies from the supply chain.
You are relying on someone’s word in many cases. Even if they sign something, can’t be 100% sure. Not being sure
scares me. I don’t think there’s a solution unless you get into testing everything.
Where is the Industry Headed
Sees us moving toward database that allows you to compare product performance and attributes.
“I think I had a better—maybe a more confident answer— maybe 2 years ago. Now I feel like I Don’t know anymore
where the industry is gonna go.”
Haven’t necessarily changed suppliers, but have gotten rid of some ingredient (a lot of PVC)
Now being more proactive about what to avoid- not just cause of transparency, but overall awareness. Big clients help
drive.
Not a massive correlation between consumer interaction and this work, but positive for sure
RSLs most practical solution. “Suppliers will go after that so much quicker nad so much better with better
information.”
Regrettable substitution is a problem, but it’s the most user-friendly.
They ask- if something is formaldehyde free, what are they using as a substitute?
Proactive vs. Reactive Materials Selection
Perhaps should focus less on finding pththalates and more on finding the best available ingredients
An hour spent tracking down potential chrome VI in a caster- is an hour less time finding a solution.
“I know we need disclosure or transparency but I want to balance it with productive changes.”
Data Management/Dynamic Supply Chains
Biggest barrier: very dynamic supply chain
Low cost in their chain could mean Tennessee, or China, but when we switch, we restart the clock.
Can control some issues with your specifications, but it’s difficult.
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Sheer number of products and materials – lots of data. Tons of product variations
Generally stick with the same supplier. Change when they have to.
That’s part of doing business, and why the cost of a chair has stayed relatively flat cost over the past number of years.
“We’re a fashion industry” – changing colors. Could be tracking materials forever.
Barriers to Better Products
In some situations there isn’t a better ingredient option

INTERVIEW 11
Educating Consumers
Communicating with market, with architects, trying to understand where they are
Lots of education created for their customers about importance of transparency, programs
Education is really important.
More Information than Understanding
“We are in an infant stage there. Caught in between what we think we know and what’s really so”
Multiple Businesses in different regulatory environments
Building products market division is far ahead of the other divisions in terms of env. sustainability
Where is the Industry Headed
Harmonization between programs very positive.
“I don’t think anything has emerged yet that is going to be the thing.”
Architects looking for 1 cert. program (i.e. GCC)- so they can side by side compare all attributes.
Living Product Challenge and Green Circle Certified are frontrunners for him.
Predicts company like Google will make publicly availably platform where you can quickly populate all products for a
project.
Hard to completely change a company based on certain product, so we need time.
Internal Learning
Inputs vs. final product: “is it’s about what’s in the finished product, and not the chemistry and reaction that goes into
it” (reporting confusion)
What is in your product vs. what you thought was in there
Started on Transparency platforms (HPD, Declare) about 2 years ago.
Self-taught about these issues.
Declare, LCAs, HPDs, EPDs, google and portico, etc has worked with all
Carpet has industry NSF140 internal certification.
Barriers to getting information from Supply Chain
Some chemicals don’t have CAS#; registered with EPA as trade secret. Won’t even disclose with NDA.
“We want to know everything. And that’s what we’re up against right now”
Can’t get all of the information yet from suppliers
Somewhat vertically integrated.
Scalability/Data Management
Dealing with how to collect data and manage in comprehensive chemical database.
Risk v. Hazard
How do you deal with risk vs. hazard?
Without risk analysis, most products wouldn’t meet LEED V4 criteria of not having any BM 1s
Internal Position
Won’t be sorted in a short period of time, in terms of figuring this stuff out as a company.
As you become more transparent, more incentive to eliminate certain ingredients
Conservative company, not going to jump on the bandwagon right away

123
Representation of Products in Standards
Manufacturers very hesitant to put HPDs out because of how your product is represented.
“No one wants to be the first to put something out that makes your product look like a carcinogen.”
Haven’t publicly published HPDs. They have Declare labels. More to learn, but they are accurate.
Need to Balance Priorities
Consultants are the way to go right now “we have a lot of irons in the fire”
Hard to figure out what to focus on
Feels good to test a product to know there are no residuals, but testing costs a lot
Lots of PhDs on staff, but often have to decide whether they want to work internally or externally
It’s not scalable to research every product, every ingredient.
Need for Industries to Address Health Concerns
Wants to get ahead of cancer rates and prevent, rather than just treating
“I’m probably different than most. I want to disclose everything”
I want to know what me and my kids, and their kids, are being exposed to.
Cancer rates are going up, so we need to start preventing, not just get better at treating it
Manufacturer as customer perspective.
“There’s nothing I’m more passionate about than this subject”
HBN did a study and recycled content can be really problematic
Within the same business, not every division is the same. One specifically makes proprietary chem.
Transparency is Important
Transparency makes a difference
People in companies make decisions because of transparency because they realize they have to disclose what’s in the
product and it’s not going away.
We have seen this change in food; who heard of gluten free a few years ago? Will change the market.
Level of disclosure: 10,000 ppm, 1,000 ppm, 100pp - what’s useful?…10,000 is not
You can’t get to 1ppm, but as we learn more, if 100ppm is no where we need to be, then head there
Red List Approach
Some materials have issues throughout the lifecycle. Don’t want workers or customers exposed.
But you can’t say all PVC is bad if it’s just the plasticizer that is bad. Has to be science behind it.
Red Lists can work, if the science is right, and if exposure standpoint makes sense.
Disclosure Format
Ok with disclosing the cooked cake, not the cake recipe.
Need for a level playing field
Didn’t want to be the first with HPDs. Have seen them manipulated, and don’t want to play games

INTERVIEW 12
Gathering Good Data from your Supply Chain
Huge amount of suppliers globally
Sustainability data management: how do you query and get consistent answers?
Where it’s made, how it’s made, what’s in it- very hard to get consistent information
Company is less and less vertically integrated all the time; very global supply chain
Even for a company of that size, sustainability department of 1 person
Goal of institutionalizing LCA and material ingredient reporting into the process
If you don’t streamline the process you will need 20 people to do the job
If suppliers would just provide HPDs, manufacturers could feed those into their products
Aggregating information down the supply chain would be preferable
Disclosure is like peeling an onion
Material ingredient reporting and supply chain work is “peeling layers of an onion”
Better you get at retrieving information and more rigorous you are, the worse the product may look
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Worst HPDs or Declare labels (least rigorous) may look the best
Twinkie = cake + frosting on the surface, but really 110 ingredients once you look deeper
Importance of Disclosure
Everyone needs to be engaged and lay their cards on the table.
“The writings on the wall. We need to be transparent. We need to know what’s in our products.”
“I want to be transparent. I think it’s great. But…in practice that is a very difficult to do.”
HPDs are a gateway- you might not publish/report, but it’s a way in
Educating Customers
Consumer end- Distributor needs to understand HPDs or else all this work was for nothing.
They have a green distributor department.
Make it easy for the architects to figure out your product.
Loves to talk to architects- that’s how they learn from their customers.
If architects don’t understand how to read HPDs or Declare labels, how will they know that cake + frosting is maybe
not accurate, or that the label with the ‘additive’ is just more complete
Lots of confusion around what people are asking for.
Must know systems better than project teams requesting them
Educating the Supply Chain
Need to educate first tier suppliers; those suppliers need to educate their suppliers.
Need to just make it part of The Ask.
Social impact is ahead of this- an error of commission
Health is still an error of omission. Need to make it an error of commission.
Gathering information on SDS down to CAS #s
Working on educating supply chain, market
Haven’t had many issues with NDAs in supply chains
Internal Approach to Materials
Already had a red list of common things in their industry, but expanded with programs
Company is not married to its ingredients; customer drives the product
Engineers + suppliers were directed to remove the unwanted ingredients
Company is not where interviewee wants them to be yet, but working on it
Transparency ability depends on the company, will take awhile to get there
Data Management Issues
“Metal” or “plastic” are not acceptable answers from the supply chain. Weight drives reporting
All of these considerations must be done without impacting price
Have to balance need for material information and RL exclusion with supplier relationship
Have to believe your suppliers to a degree- you do a spot check, desk audit
Has started to see substitutions happen and get better information
How do you capture everything, all the information, though?
Barriers to getting good data from Supply Chain
Some testing of products to see how accurate reporting is, but testing is expensive
Have to take information at face value at some point. Can’t audit everyone, can’t test everything
Dynamity - 1 part from 4 suppliers. Can’t tell you which day you buy part from which suppliers.
We can only go so deep on disclosure
Can’t report lower than Global Homogenous Materials. Can’t go beneath stainless steel
If we go too deep in materials, too big of a conversation.
I can’t impact what’s in my recycled steel
Need to Balance Attributes of Products
They have other things to watch as well: recycled content, buy America, regionality, etc
Simplicity of Hazard Approach + Red List
Hazard vs. Risk: I like the hazard approach because I can know what to avoid. Clean approach.
Red List is more scalable, so it’s preferable. “Amen. Hallelujah. I got it”
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Red List vs. actual risk
Need to prioritize efforts
But if it’s phenol formaldehyde and it’s CDPH-compliant so no risk, what are we talking about?
Need to focus on highest-level risks.
Not focusing on how to avoid regrettable substitutions- just going on current and future regulation
Getting HPD requests for tiny components- have to prioritize based on cost and importance
Recycled content: “there’s probably zero risk for what’s in there”
Changes happening in industry
Things have changed hugely in 3 years in the industry
Food analogy- things will change like they did for food industry.
Pharma: each batch is highly traceable. Not necessary for door bumpers, but still, for some maybe
Starting to be more pathways for which direction you want to go to (HPD data, turn into Declare label, put in Google
portico, etc.)
Program Output
Some responsibility for communicating on formats lies with the manufacturer- HPD comment space
No space to talk about risk/context on Declare label; “yes it’s Red List, but it’s an exterior product”
C2C is more simplistic. But the manufacturer is paying for the certification that org. is providing.
If had 6 products, would do C2C “just be done and get some magic certification” but too many SKUs
But the manufacturer doesn’t want to be a toxicologist. Want to trust C2C gold etc.
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Material Health Evaluation  Thesis Survey AM
INFORMED CONSENT

i.

Informed Consent Form
Introduction
This study attempts to collect information about the integration of voluntary material health evaluation
programs into manufacturing companies in the U.S. building products industry.
Procedures
This questionnaire consists of 26 questions and should take approximately 10 minutes or less to
complete. Questions are designed to determine relative familiarity with these programs as well as your
company's perspective on material health reporting.
Confidentiality
All data obtained from participants will be kept confidential and will only be reported in an aggregate
format (by reporting only combined results and never reporting individual ones). No participant names
or company names are collected as part of the survey. All questionnaires will be concealed, and no one
other than then primary investigator listed below will have access to them. The data collected will be
stored in the HIPAAcompliant, Qualtricssecure database until it has been deleted by the primary
investigator.
Compensation
There is no direct compensation.
Participation
Participation in this research study is completely voluntary. You have the right to withdraw at anytime or
refuse to participate.
Questions about the Research
If you have questions regarding this study, you may contact Dr. Michael Dyrenfurth, at 765496
6160, mdyrenfu@purdue.edu or Alexandra Muller, 5162200292, muller2@purdue.edu.
Questions about your Rights as Research Participants
If you have questions you do not feel comfortable asking the researcher, you may contact Purdue's
Institutional Review Board at 7654945942, irbquestions@purdue.edu.

https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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ii.
I have read, understood, and printed a copy of, the above consent form and desire of my own free will
to participate in this study.
Yes
No

COMPANY BACKGROUND

Q1. Which best describes your company's role in the supply chain? (Select all that apply)
Produce chemical substances, mixtures of chemicals or materials
Produce components
Assemble products
Sell finished goods to other businesses
Sell finished goods to consumers
Other (please describe)

Q2. What types of products does your company manufacture? Select all that apply:
Appliances

Insulation

Bathroom fixtures

Lighting

Ceilings / Acoustics

Masonry

Chemicals

Paint

Coatings

Plumbing

Concrete

Railings

Doors

Roofing

Electrical

Shading

Elevators

Walls

Flooring

Windows

Furniture

Wood products

Hardware

Other (please describe):

HVAC

https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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Q3. How many employees are there in your company?
1  49 employees
50  249 employees
250  1,000 employees
1,000  5,000 employees
5,000  10,000 employees
More than 10,000 employees

Q4. What is your company's annual revenue? (in USD)
Less than 1 million
1 million to less than 10 million
10 million to less than 25 million
25 million to less than 100 million
100 million to less than 250 million
250 million to less than 1 billion
More than 1 billion

Q5. How would you describe your team at your company:
Sustainability
Legal
Compliance
Design
Sales
Marketing
Research & Development
Chemical Policy
Other (please enter below):

https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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Q6. What is your role in that group?
VP
Director
Manager
Engineer
Other (please describe):

Q7. If you interact with material health evaluation, disclosure or chemicalsrelated issues at your
company, please briefly describe your role:
Describe:
I do not interact with issues of material health evaluation or certification at my company.

Q8. Including yourself, how many employees work directly on issues of material health and material
health program compliance at your company?
0
1
2
3
45
610
11+

AWARENESS & USE OF MATERIAL HEALTH DECLARATION / EVALUATION PROGRAMS

Q9. Please indicate your familiarity with the following material health declaration and evaluation
programs/standards:

Never heard of it

Heard of it, but minimal
knowledge

https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview

Familiar with the
standard but haven't
used it

I have engaged with the
program
4/11
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Declare
Cradle to Cradle Certified
Product Standard
Health Product Declaration
(HPD)
BIFMA Level
GreenScreen for Safer
Chemicals

Q10. How many products in your company have been disclosed/evaluated by each of the following
programs?
0

14

59

10+

Not sure

Declare
Cradle to Cradle Certified
Product Standard
Health Product Declaration
(HPD)
BIFMA Level

Q11.
Please rearrange the following programs or standards to reflect the relative number of requests your
company gets for each (1 being the most requested, 4 being the least requested)

Declare label
Health Product Declaration
Cradle to Cradle certification
BIFMA Level certification

COMPANY APPROACH TO MATERIAL HEALTH

Q12. How greatly do the following factors influence your engagement with issues of material health
and material health programs?
Not at all

A little

Somewhat

A lot

Consumer demand

https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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Building Certification Programs
Anticipated Future regulation
International regulation
Company mission + values

Q13.
Responding to requests for material health evaluation/declaration has:
Strongly
Disagree

Disagree

Neither Agree
nor Disagree

Agree

Strongly Agree

N/A

Increased internal understanding
of our products
Increased consumer confidence
in our company
Significantly changed our
relationships with suppliers
Altered our relationships with
architecture firms
Changed our relationship with
competitors
Improved our competitiveness

SUPPLY CHAIN INTERACTION

Q14. Approximately how many first tier suppliers are in your supply chain?

Q15. How many suppliers would you estimate there are in your entire supply chain?

Q16. Is your supply chain
Domestic
https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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Global

Q17. What percentage of your supply chain have you engaged to collect ingredient and health
information?
110%
1125%
2650%
51100%
Not sure

Q18. How does your company communicate material health requirements to your suppliers? (Check all
that apply)
Use of a Restricted Substances List (RSL) to screen suppliers
Requesting that suppliers complete an HPD for product components
Requesting SDSs from suppliers
Use of a 3rd party to collect chemical information
Using an internal data collection process
Other:

Q19. Was your company's Restricted Substances List (RSL) (Select all that apply):
Created internally
Based on regulatory standards (please list below)
Pulled from a particular material health standard (please list below)
Other

Q20. Which of the following measures has your company used to verify the chemical content of a
product?
https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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Letter from a supplier
3rd party engagement of the supply chain
Laboratory testing of product content
None
I'm not sure

Q21. Which of the following tools has your company used to avoid regrettable substitutions?
Restricted Substances Lists
Internal database of vetted chemicals
Conducting a GreenScreen assessment
Using the GreenScreen List Translator and/or Pharos Chemical and Material Library
Hiring a 3rd party consultant to assess new options

COMPANY PERSPECTIVE ON MATERIAL HEALTH INFORMATION

Q22. In your opinion, how useful is it to consumers for manufacturers to communicate each of the
following aspects of material health?

Very Useless

Somewhat
Useless

Useless

Somewhat
Useful

Useful

Very Useful

Presence or absence of
Chemicals of Concern
Full list of product ingredients
and CAS #s
Ingredient hazard rating
Productlevel risk assessment

Q23. Please assess the following attributes of a voluntary material health evaluation program in terms
of their their relative importance to your company (1 being least important, 5 being most important)
Least Important
1

Most important
2

3

4

5

Requiring public disclosure of
ingredients
Hazard assessment of
ingredients
https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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Risk assessment of product
Program/Standard transparency
Selfdisclosure
3rd party certification

Q24. Engagement with material health evaluation programs/standards has:

Strongly Disagree

Disagree

Neither Agree nor
Disagree

Agree

Strongly Agree

Increased internal understanding
of our products
Increased our supply chain
engagement
Led to changes in our supply
chain
Led to changes in our product
chemistry
Increased consumer confidence
in our company
Acted as a platform for our
company to differentiate itself
Led to increased revenue

Q25. Please assess the following programs in terms of their:
Ability to communicate with the
A+D Community
Ineffective

Somewhat
Very
effective effective

Potential as a decisionmaking
tool for A+D Professionals
Ineffective

Somewhat
Very
effective effective

Ability to confer a market
advantage
Ineffective

Somewhat
Very
effective effective

Declare
Cradle to Cradle
GreenScreen
Health Product
Declaration (HPD)
BIFMA Level

Q26. How relevant are each of following barriers to further public disclosure of your company's product
ingredients? (1 being the least relevant, 5 being the most relevant)
Least relevant
https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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1

2

3

4

5

Company inertia
Dynamic or fluid nature of supply chain
Supply chain resistance to ingredient
disclosure
Lack of demand for transparency from
consumers
Need for greater internal education to
interpreting information
Need for supplier education around
material health disclosure
Difficulty in gathering and managing large
amounts of information
Lack of obvious leading
disclosure/evaluation program in market,
market confusion
My company's trade secrets/proprietary
information
Supply chain's trade secrets/proprietary
information
Time and expense of determining product
content
The market is too competitive for us to
reveal further information
More information makes products appear
more dangerous
Other (Please describe)

TRANSPARENCY + REGULATION

Q27. Which do you feel is more likely to lead to a healthier materials market?
Marketdriven solutions
Federal regulation
I don't know

Q28. Please define 'transparency' as it pertains to the building material industry:

https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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Q29. Please define 'material health' as it pertains to the building material industry

Qa. Optional: please enter any additional thoughts/comments on the topic of material health and
disclosure in manufacturing:

https://purdue.qualtrics.com/ControlPanel/Ajax.php?action=GetSurveyPrintPreview
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